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ABSTRACT
 The purpose of this dissertation project is to add to the growing literature about 
the multi-faceted aspects of colorectal cancer (CRC) prevention and related disparities. 
We focused on the spatial distribution of facilities performing screening services to 
identify areas that underutilize colonoscopy screening. Next, we examined how the food 
and physical activity environment affects precursors of CRC by considering plausible 
pathways. Finally, we explored if access to health insurance reduced the racial disparity 
of receiving a timely surveillance colonoscopy after a CRC diagnosis.  
We utilized the SC Ambulatory Surgery Discharge Database, an all-payer, 
population-based outpatient dataset with colonoscopy records from 2000 – 2014. To 
identify individuals with a personal history of CRC, we used the SC Central Cancer 
Registry. We used the Colorectal Cancer Prevention Network screening cohort of low-
income, uninsured adults in SC to study colorectal polyps. We paired these unique 
datasets with innovative analysis methods like two-stage Bayesian hierarchical logistic 
regression, causal mediation analysis, and loglinear regression. 
We were able to create catchment areas (CAs) for all facilities in SC performing 
screening colonoscopies and found that only a small proportion of ZIP codes were not 
included in any CA. Aspects of the food and physical activity environment had a direct, 
protective effect on having high-risk colorectal polyps. Finally, we found that over time, 
increased access to health insurance helped to diminish the racial disparity in receiving a 
timely surveillance colonoscopy. 
vi 
Overall, this dissertation was able to address gaps in the literature, particularly 
providing risk and prevalence estimates for the state of South Carolina (SC). This work 
lays the foundation for addressing screening and surveillance capacity in SC and 
understanding the individual role within unhealthy environments.  
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Colorectal cancer (CRC) is cancer of the large intestine (colon) or rectum; it is 
considered a disease of the developed world.1 Overall, men and women in the United 
States have approximately a 5% lifetime risk of developing colorectal cancer2, and it is 
the third most common cancer, affecting mostly adults over 50 years old. For 2017, the 
American Cancer Society estimated that 67,800 deaths were attributable to CRC.3 More 
specifically, CRC was estimated to be the second leading cause of cancer death in the 
United States (U.S.) and South Carolina (SC) for the same year. 
CRC is largely preventable through primary and secondary prevention methods 
and reduce the risk of CRC through maintaining a healthy lifestyle, which include a 
healthy diet (5-8%), physical activity (16%), not smoking (12%), and regular screenings 
(63%).1,4–6 Screening has become more affordable over the last two decades due to 
Medicare’s determination to cover colonoscopy for average-risk individuals in 2001 and 
the more recent Affordable Care Act making screening available to nearly all insured 
average-risk individuals with no out-of-pocket costs, yet only 67.6% of eligible adults 
have received any type of screening.7 Research has shown that the barriers to CRC 
screening include lack of awareness, affordability, distance to a screening facility, lack of 
symptoms, and views of cancer fatality.8–10  
CRC survival is relatively high compared to other cancers, but dependent on 
numerous factors. The five-year survival is 65% overall, and ranges from 14% to 90% for 
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distant and localized stage, respectively.3 Research on survival and recurrence after a 
CRC diagnosis is limited, and somewhat inconclusive.11 However, it is suggested that 
primary prevention methods like reduced processed food consumption and physical 
activity reduce recurrence after a CRC diagnosis as well.12,13 In addition, consistent 
surveillance is recommended to prevent CRC recurrence. Colonoscopy is primarily 
recommended, however the method and intervals of testing vary by family history, polyp 
size, age, and location of the tumor.14,15 Factors preventing prolonged survival include 
financial burden16,17 and lack of social support18,19. 
 
1.1 Statement of the Problem  
Over the last two decades, there has been an overall decrease in CRC mortality in 
the U.S. population.3 This may be due to increased CRC screening and improved 
treatment. While any reduction in CRC morbidity or mortality is considered a victory, 
certain populations are still at a disadvantage compared to others. There are consistent 
disparities in CRC outcomes between Black and White Americans,4,20 lower and upper 
SES,21 and rural and urban Americans22,23. Compared to Whites, African Americans are 
more likely to be diagnosed with and die from CRC.3,24 This could be due to less 
understanding about screening and lower screening rates, even when there is a known 
family history of the disease.24,25 African Americans are also more likely to be diagnosed 
at later stages, which is directly related to survival.25–27 In addition, individuals of lower 
socioeconomic status have a higher risk of CRC incidence and mortality.25,28 This 
disparity is not always mitigated by insurance.29–31 Finally, compared to those residing in 
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urban areas, rural residents are less likely to receive screening, have higher CRC 
incidence rates, and later stages at diagnosis.22,23,32,33  
Progress in reducing colorectal cancer death rates and disparities can be 
accelerated by improving access to screening/surveillance, and providing high-quality, 
timely treatment in all populations.20 Particularly in South Carolina, there is large 
intersectionality of African American living in rural areas compared to the national 
distribution34, and due to the lack of Medicaid expansion, high rate of no insurance, and 
large minority representation, these disparities may be compounded. Similar disparities 
are noted for prevention opportunities like access to affordable healthy food outlets.35,36 
Across the U.S., predominately rural, low income, or ethnic minority communities have 
less access to quality food and supermarkets,37 which is directly related to chronic 
diseases like CRC. 
 
1.2 Purpose & Aims 
The purpose of this project is to investigate disparities in travel patterns of CRC 
screening (Paper 1), obesogenic environmental effects on CRC screening outcomes 
(Paper 2), and adherence to post CRC diagnosis surveillance (Paper 3) in SC.  
Aim I: To determine the catchment areas of facilities performing screening 
colonoscopies and the associated travel patterns of their patients in South Carolina. 
The purpose of this project is to illustrate and describe the catchment areas (CA; i.e. 
service area) of facilities in SC providing screening colonoscopies from 2010 – 2014. 
Catchment area analyses help describe the types of people that are more likely utilize a 
service in specific locations. Using data from the population-based SC Outpatient 
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Ambulatory Discharge database, we will construct CAs and examine travel patterns of 
age-eligible adults seeking a screening colonoscopy. The following research questions 
will be answered within this aim: 
1. What is the greatest distance that patients are willing to travel? How does it differ 
by patient rurality?  
2. What are the characteristics of patients inside and outside of the catchment areas? 
Aim II: To determine the relationship between the obesogenic environment and the 
presence of colorectal polyps among patients screened for CRC. Poor access to 
recreational opportunities and healthy food outlets can be barriers to living a healthy 
lifestyle, and are more pervasive in low-income and rural neighborhoods.38,39 Although 
the environment is a social determinant of health, its role in CRC has not been clearly 
established, as studies have produced mixed results.40–42 Using a low-income, uninsured 
screening cohort from the Colorectal Cancer Prevention Network sponsored by the 
University of South Carolina, we propose to: 
1. Examine the pathways between the obesogenic environment and the presence of 
CRC polyps. 
2. To explore whether the association of the obesogenic environment on the 
presence CRC polyp(s) differs by polyp type (any and high-risk). 
Hypotheses:  
1. The pathway between the obesogenic environment and having a polyp is mostly 
mediated through obesity. 
2. The direct pathway (not through individual-level obesity) has a stronger effect on 
high-risk polyps than the general class of polyps. 
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Aim III: To determine if racial disparities in CRC surveillance adherence diminish 
over time with increased access to health care as measured by insurance 
coverage. CRC survivors are at an increased risk of CRC recurrence. After a cancer 
diagnosis and treatment, there are several steps that a survivor can take to protect their 
quality of life; surveillance is a key step. A surveillance colonoscopy is recommended 
one year after a colorectal cancer (CRC) diagnosis and treatment to detect early signs of 
recurrent cancer.43 Adherence to this recommendation varies widely, and uptake is 
suboptimal among minority populations.44 Using data from the SC Outpatient 
Ambulatory database linked to the SC Central Cancer Registry, we propose to: 
1. Describe surveillance uptake overtime in SC among patients diagnosed with 
CRC. 
2. To examine racial disparities in adherence to surveillance by age group over time. 
Hypothesis: The disparity between older (≥ 65) African American and White patients is 
significantly reduced for colorectal cancer surveillance adherence due to increased access 
to health care through insurance. 
 
1.3 Significance & Rationale  
In 2014, the National Colorectal Cancer Roundtable announced an initiative to 
screen 80% of age-eligible adults by 2018. In the same year, approximately 68% of SC 
adults aged 50 and over were up-to-date on any CRC screening.45 Population screening is 
imperative in reducing the incidence and mortality of CRC, therefore it is important to 
establish and verify beneficial agents and potential barriers to receiving CRC-related 
services. In SC, the clusters of centers performing colonoscopy, particularly in urban 
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areas, may create pockets of poor accessibility to colonoscopy services where people 
must travel a great distance to be screened for CRC. Therefore, it is of great interest to 
visualize and understand the catchment areas of these centers, and the corresponding 
population that they reach and attract. This analysis (for Aim 1) has not been done for 
colonoscopy centers in SC and has the potential to inform the colonoscopy centers of the 
range of their service. 
It is widely known that living in a healthier environment, or an environment with 
health-promoting opportunities, is associated with better health outcomes. However, the 
relationship between the obesogenic environment and CRC has not been well established. 
Aim 2 seeks to determine if areas with less healthy options influence colorectal outcomes 
outside of the known pathway through obesity. A significant finding would draw 
attention to neighborhoods that appear “unhealthy” to determine a true cause of the 
outcome. 
Finally, adherence to surveillance after a CRC diagnosis is not as well studied as 
CRC screening. Aim 3 will establish the prevalence of surveillance uptake in SC over 
time and across racial/ethnic and age groups, which currently does not exist. This is an 
important step in recognizing how disparities change over time and potential intervention 







The colon, or the large intestine, removes water, breaks down and extracts 
remaining nutrients in the digestive process. Using the muscles that line the colon wall, 
the residual contents, called stool, are pushed to the rectum, then finally out of the body 
through the anus. The colon is comprised of four sections: the ascending, transverse, 
descending, and sigmoid colon. The ascending colon begins at the cecum, which 
connects the colon to the small intestine, and runs up the right side of the abdomen. The 
transverse colon runs above the abdomen and is the connection between the ascending 
and descending colon. The descending colon runs down the left side of the abdomen, 
connects to the sigmoid colon, which is joined to the rectum. The ascending and 
transverse colon are also referred to as the proximal colon, and the descending and 
sigmoid are referred to as the distal colon. Together, the colon and rectum are 
approximately six feet long. 
The colon is a tubular organ with multiple layers. The innermost layer of the 
colon and rectum is the mucosa. The mucosa is comprised of the epithelium, connective 
tissue or the lumen, and thin strips of muscle. The submucosa is a layer of connective 
tissue containing mucous glands, blood vessels, lymphatic vessels, and nerves 
immediately beneath the mucosa. The muscularis propia is a thick layer of muscle that 
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lies just below the submucosa. Finally, the serosa is the outermost layer and the only 
layer not found on the rectum. 
 
2.1.1 Polyps 
In certain situations, the mucosal layer can become hyperproliferative and form a 
benign growth called a polyp. Polyps can be complex, vary in size, and location of the 
colon and rectum. Inflammatory, hyperplastic and adenomas (i.e. adenomatous polyps) 
are the most common. Inflammatory polyps are typically found in the colon of those with 
inflammatory disease like Crohn’s disease or ulcerative colitis.47 Inflammatory and 
hyperplastic polyps typically will not develop into cancer, and they both can be removed 
during a colonoscopy.47,48  
 
2.1.2 Adenomas 
Adenomas arise from the glandular cells found on the mucosal surface; the 
purpose of these cells is to produce the mucous that lubricates the colon and rectum. CRC 
develops through one of three pathways: 1) the adenoma-carcinoma pathway (most 
common for sporadic CRC), 2) the CpG island methylator phenotype (CIMP), high 
microsatellite instability, and 3) the microsatellite instability through mismatch repair 
pathway.49,50 Adenomatous polyps are precursors to CRC and account for 96% of all 
CRCs.7 These polyps arise through the first pathway and can be classified into tubular, 
villous, tubulovillous (a mix), or serrated. Tubular adenomas are protruding, spherical, 
and pedunculated (i.e. elongated) and account for about 80% of adenomas found in the 
colon and have a less than a 5% chance of progressing to cancer.51 Tubulovillous 
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adenomas account for 10 – 15% of adenomas and have an elevated risk of malignancy of 
20 – 25%.51 Villous adenomas are typically sessile with a hairy-like surface, account 
about 5 – 10% of adenomas, and have between 30 – 45% chance of progressing to 
cancer.51 Serrated adenomas have a sawtooth appearance and are responsible for 
approximately 30% of colorectal cancers.52 
Serrated adenomas/polyps arise from the CIMP pathway and can be classified as 
hyperplastic, sessile, and traditional. This pathway is particularly important because 
individuals with serrated polyps have a higher risk of CRC compared to individuals with 
other advanced adenomas.53 Traditional serrated adenomas are smaller in size and rare, 
and sessile serrated polyps are typically located in the proximal colon and tend to be 
missed during endoscopic procedures, which leads to interval cancer.52,54 Because of the 
malignancy of serrated polyps, surveillance after a polypectomy are more frequent than 
the standard 10 year interval, ranging from 3 – 5 years.50,55  
The Microsatellite instability (MSI) pathway is caused by mutations in the 
mismatch repair (MMR) gene. Microsatellites are short repeats of DNA sequences. 
Instability occurs when the number of repeats is different from the number of inherited 
DNA repeats.56 Previous research has estimated that MSI accounted for 13% of sporadic 
CRC.57 MSI tumors are mostly found on the right side and individuals diagnosed with a 






2.2 Biological Causes of Colorectal Cancer  
CRC is a consequence of genetic and epigenetic mutations that transform normal 
tissue into adenocarcinoma.60 Like most cancers, CRC is a multifactorial disease, and 
results from the inability to control cell replication and differentiation.61 For example, 
inactivation of tumor suppressor genes due to DNA mutation can trigger tumorigenesis. 
Tumorigenesis, or the initiation of CRC, develops overtime from precancerous polyps. In 
the most common pathway, these polyps advance in size from small to larger 
adenoma(s), then finally to cancer.62 While large adenomas are associated with higher 
malignancy, most adenomas found in the colon or rectum are small, having a diameter 
less than one cm.63,64 
Genetics play a role, with increased predisposition to CRC related to familial 
diseases, like Lynch Syndrome or Familial Adenomatous Polyposis. Of note, these high 
risk individuals only account for 5 – 10% of all diagnosed cases.65 Another known 
pathway to CRC is through aberrant DNA methylation. DNA methylation is the process 
of activating or silencing cell activity. Previous research has shown that aberrant 
hypermethylation in specific regions has the potential to silence tumor suppressor genes; 
the downstream effect is the same as mutation-induced inactivation of tumor suppressor 
genes as previously discussed.60 Increasing evidence shows a connection between 
lifestyle factors and epigenetic modification. Raskov et al. noted that mucosal cells 
quickly adapt to carcinogens and diet changes which result in epigenetic changes, and can 
result in tumor formation; these changes can be amplified if genetic predispositions 
already exist.66  
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Many of the molecular-focused studies consistently found smoking to increase the 
risk of CRC through the serrated pathway, with the highest risk (Hazard Ratio ≈ 2) 
associated with MSI.62 Smoking cessation was found to have a protective effect on the 
DNA methylation pathway where at least 10 years of cessation was associated with a 
50% lower risk of CIMP-high CRC.67 The effect of dietary patterns also differed by 
microsatellite stable (MSS) tumors where an increased consumption of red meat, total 
and saturated fats, and cholesterol were associated with increased odds of CRC.68 Some 
epidemiologic studies have also found obesity to be positively associated with CRC for 
MSS tumors.69,70 
 
2.3 Disease Progression 
The progression from onset to colorectal cancer symptoms can take up to 20 years 
for the average risk population, or as little as three years in patients with familial 
predisposition for familial diseases.2,60 CRC typically begins as a small adenomatous 
polyp and the probability of cancer increases as the adenoma grows.4 Approximately 30 – 
50% of individuals will develop at least one adenoma, but less than 10% progress to 
cancer.71 Adenocarcinoma, developed from abnormal proliferation of the glandular cells, 
is the most common form of CRC (96% of cases).7 The stage of CRC indicates the 
severity, or spread of cancer. CRC begins on the inner lining of the colon or rectum (in 
situ), expands to the colon or rectum wall (local), into the lymph and blood vessels 
(regional), then into other organs (distant).4 Approximately 38% and 43% of patients are 
diagnosed with colon and rectum cancer at the localized stage, respectively, where the 
survival rate is highest.7 
12 
There are usually no signs or symptoms at the onset and early stages of CRC. As 
the cancer develops, individuals may experience bloody stool, bleeding from the rectum, 
a change in the color or shape of stool, discomfort in the abdomen area, unintentional 
weight loss, vomiting, constipation or diarrhea, or a decreased appetite.72 Although there 
are a lack of symptoms in the progression of CRC, it can be caught early or prevented 
with various screening methods. 
 
2.4 Observational & Randomized Control Trial findings  
CRC is a multifactorial disease that is influenced by both modifiable and non-
modifiable risk factors. There are two hereditary patterns related to CRC, those that are 
associated with colon polyps (polyposis) and those that are not (non-polyposis). 
Individuals with a family history have the greatest lifetime risk of developing CRC. 
Those with one first-degree relative diagnosed CRC have two times the risk, and those 
with more than one relative have four times the risk of developing CRC.73 Epidemiologic 
studies also show an association between incidence of sporadic CRC and lifestyle 




Familial Adenomatous Polyposis (FAP) is a genetic disorder that has both 
autosomal dominant and autosomal recessive forms, and has an incidence of 1 per 8,000 
– 10,000, which only accounts for <1% of all CRC cases.1,76 An individual with FAP can 
develop hundreds to thousands of colonic polyps that increase in frequency with age; 
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these polyps can progress to cancer if not removed. In the milder (recessive) form of 
FAP, an individual can develop less than 100 polyps over a lifetime. Individuals with 
FAP or attenuated FAP have almost a 100% lifetime risk of developing CRC, which is 
significantly greater than the sporadic forms. The average age of CRC onset is 39 for 
FAP and 55 for attenuated (delayed) FAP, compared to 69 for the average risk 
population. The cause of FAP and its attenuated form is a mutation of the adenomatous 
polyposis coli (APC) gene, a tumor suppressor gene that control normal cell growth and 
function.77 The cause of autosomal recessive FAP is a mutation in the MUTYH gene, 
which controls DNA correction during the replication process before cell division.  
Lynch syndrome (LS), or hereditary nonpolyposis colorectal cancer, is an 
autosomal dominant that accounts for 3% of the new cases of CRC.78 LS manifests 
through the MSI pathway by variations in the MMR genes: MLH1, MLH2, MLH6, 
PMS2, and EPCAM.57,79 Similar to FAP, these genes are involved in repairing errors 
during DNA replication. The continuation of more cells dividing and replicating with 
errors leads to uncontrolled cell growth, and possibly malignant tumors. LS does not only 
lead to CRC, it can lead to cancer of related and distant organs like the digestive organs, 
the upper urinary tract, brain, and skin.78 
 
2.4.2 Polyp Location 
 The location of a colon polyp or adenomatous tissue has implications for the 
severity and survival of CRC. Individuals with right-sided cancer are more likely to 
experience interval cancer (i.e. cancer between screenings),80 and have a higher risk of 
mortality.58,81 The increase in mortality is related to right-sided cancers being diagnosed 
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at later stages and in older adults, which leads to poorer survival compared to left-sided 
cancers.81,82 Although colonoscopy is effective in reducing the incidence and mortality of 
CRC, the reductions are lower for the proximal (right side) compared to distal cancers.54 
It is hypothesized that these differences are attributable to some polyps, like serrated, in 
the proximal (right) region being harder to detect. Adenomas and serrated polyps, 
specifically sessile serrated, are more likely to be in the proximal colon than distal.83 
Large serrated polyps were found to be a strong risk factor for CRC, particularly for 
proximal cancers.84 Further, Qumseya et al. found that a right-sided polyp is three times 




Advanced age is also a known risk for various chronic diseases like colorectal 
cancer. Approximately 90% of diagnosed CRC cases occur in adults 50 years and older, 
and over 70% in adults between the ages of 50 and 80 years.86 The number of colorectal 
polyps, low and high risk, also increase with age.2,87,88 Therefore, CRC screening exists 
primarily in this age range. Although the average age of diagnosis is 69, the CRC 
incidence and mortality rate is growing in the younger population, individuals younger 
than 50 years old.7 Even though younger patients are more likely to have hereditary 
diseases, most of the cases are sporadic with no family history.89,90 Because screening is 
not recommended or covered by insurance for average-risk, young adults, this population 
tends to be diagnosed after symptoms manifest and in advanced stages.89,91,92 However, 
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even when diagnosed in later stages, younger patients have survival at least as good as 
older CRC patients.91 
 
2.4.4 Sex 
Males have consistently had a higher CRC incidence and mortality rate than 
females, even as the overall rates continue to decrease. This is consistent across race, age, 
and colorectal sites.93 The median age of diagnosis is 68 for men and 72 for women7, and 
a similar mortality age gap is seen across multiple developed nations.94 While men and 
women have similar stage at diagnosis, women have a higher 5-year survival, particularly 
for individuals under 65 years.95,96 Men also have a higher prevalence of adenomas.83,88 
In SC screening cohorts with similar socioeconomic status and health care access, more 
adenomas and cancers were detected in men compared to women.97,98 
The differences in CRC outcomes can be attributable to differences in biology, 
and lifestyle factors. Microsatellite instable tumors have better prognosis than non-MSI 
tumors, and are more prevalent in women than men.99 The difference in penetrance of LS 
(i.e. women have lower lifetime risk of CRC) was attributable to lifestyle factors like 
diet, smoking habits, and estrogen exposure.100 Epidemiologic studies have estimated a 
20% reduction in colon and rectal cancer diagnosis and increased CRC survival for 
postmenopausal women who ever used hormone replacement therapy.100 Women overall 
have a more consistent relationship with a physician, tend to be more knowledgeable 
about health literacy, and more willing to participate in CRC screening.101,102 Further, 
single men (including those divorced, separated, or widowed) have a lower screening 
prevalence than those that are married or in a committed relationship.103 
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2.4.5 Race/Ethnicity 
Ethnic minorities, particularly African Americans, have a higher incidence and 
mortality of CRC compared to White Americans.3 While the burden of disease has 
decreased over time, this disparity has remained constant.3,20,26,104 The incidence of CRC 
per 100,000 persons was 49.2 for African Americans, 45.7 for American Indian/Alaska 
Natives, 40.2 for White, 35.5 for Hispanic, and 32.2 for Asian Americans.7 The disparity 
is consistent for CRC mortality as well; per 100,000, there were is 20.5 deaths for African 
Americans, 16.4 for American Indian/Alaska Native, 14.6 for White, 11.7 for Hispanic, 
and 10.3 for Asian Americans. African American and American Indian/Alaska Natives 
are also more likely to be diagnosed at later (distant) stages and have slightly lower 5-
year survival rates.7 
Research has consistently reported the differences in polyp distribution between 
African Americans and Whites. African Americans have a higher prevalence of proximal 
or right-sided polyps compared to Whites.105–107 These findings are consistent with later 
stage diagnosis, and higher incidence and mortality for African Americans. These factors 
can be mitigated through regular screening. Screening is known to reduce the incidence 
and mortality of CRC108–111, and accounts for approximately 40% of the racial disparities 
in these CRC outcomes.86 Screening has increased for all US adults, but the racial 
disparities, like incidence and mortality, have remained persistent over time. The 2015 
National Health Interview Survey (NHIS) estimates that 61.8% of African American, 
54.3% of American Indian/Alaska Native, 65.4% of White, 49.9% of Hispanic, and 
54.3% of Asian Americans were up-to-date on CRC screening of any kind.86  
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While race is genetically assigned and not modifiable, Simon et al suggested that 
disparities in CRC are not racially-related, but rather sociodemographic.112 This is 
supported by the fact that, globally, African nations have significantly lower incidence 
and mortality rates compared to African Americans.113 In South Carolina CRC screening 
programs for low-income and uninsured adults, there was no racial difference in the 
prevalence of polyps and adenomas.97,98 Likewise, in the national Prostate, Lung, 
Colorectal, and Ovarian Cancer (PLCO) Screening Trial, a similar proportion of African 
American and White participants had abnormal flexible sigmoidoscopy reports, however 
African Americans were significantly less likely to receive a follow-up colonoscopy 
compared to Whites.31 And among those that received the diagnostic colonoscopy, there 
were no significant differences in the presence or severity of adenomas. In addition, a 
national study on cancer survivorship found that the odds of cost-related medication non-
adherence in older African American and Hispanic survivors were over two times the 
odds of White survivors.16 
 
2.5 Lifestyle  
Maintaining a healthy diet and physical activity (PA) is not only important for 
aiding in healthy body weight, but a healthy colon as well. Exhibiting a healthy lifestyle 
is the first line of defense in preventing chronic disease. The American Cancer Society 
(ACS) recommends that individuals should tailor their diets to maintain a healthy body 
weight, limit red and processed meat consumption, eat 2-3 cups of fruits and vegetables 
daily, and choose whole grains.114 Research has consistently shown that the regular 
consumption of foods high in fiber lowers the risk of CRC.66,115–117 The function of the 
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colon is to extract energy through fermentation of undigested food remnants.66 Insoluble 
fibers, found in wheat bran foods, balance and control intestinal pH, and increase and 
move fecal bulk through the intestines, which reduce mucosal exposure to potential 
carcingens.115  
Regular PA reduces the risk of chronic disease through the obesity pathway.114 
Globally, obese men and women have a higher risk of CRC than non-obese adults.118 PA 
is also thought to have a direct impact on CRC as well, like decreasing gastrointestinal 
transit time, thus reducing exposure time to carcinogens and lowering insulin levels.119 A 
recent meta-analysis estimates an 23% overall risk reduction in CRC for physically active 
adults, and an even lower reduction (44%) for adults with no family history.120 Likewise, 
a 25% reduction in CRC-specific and all-cause mortality was estimated for pre-cancerous 
adults that participated in any PA with an increased protective dose-response effect for 
higher levels of PA.121 Similar reductions in CRC incidence and mortality were observed 
for adults with higher BMI and smokers.122–124 
Cigarette smoking and alcohol consumption are the top modifiable risk factors 
attributable to CRC incidence behind physical inactivity, accounting for 11.7% and 
12.8% of cancer cases, respectively.75 Longer duration and higher intensity of smoking 
were both found to be associated with an increased risk of CRC.125 Along with current 
smokers carrying a higher risk than former smokers,126 they also have worse overall and 
CRC-specific survival.127 In addition, heavy drinkers, or those that consume a high 
volume of alcohol were consistently found to have an increased risk of CRC compared to 
non or light drinkers.128–130 More specifically, a national study found that unhealthy 
lifestyle factors contribute significantly to the SES disparities seen in CRC risk.131 
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2.6 Screening 
Screening is considered secondary prevention and is most effective if performed 
before disease symptoms arise. In 2010, approximately 63% of CRC deaths were 
attributable to lack of screening.132 Average-risk adults are advised to undergo CRC 
screening between the ages of 50 and 75. Because sporadic CRC occurs at younger ages 
for African Americans, screening begins at age 45 for this population.133 However, 
because of the increasing incidence in younger adults, the ACS updated the guidelines 
and recommends screening to begin at age 45 for all adults.134 High-risk adults, or those 
with a family history, are screened more frequently and begin at earlier ages. There are 
various screening modalities that are currently in use by individuals and medical 
professionals. These methods can be broken up into three classes, from easy (cost and 
administering) to difficult: stool, imaging, and optical tests.  
 
2.6.1 Stool Tests 
Stool tests are relatively simple and can be completed without a physician. Stool 
tests detect blood in the stool, even if not visually noticeable, because CRC lesions 
(benign and cancerous) are more likely to bleed.135 The Fecal Occult Blood Test (FOBT), 
Fecal Immunochemical Based Stool Test (FIT), and DNA Stool tests are among the most 
popular. FOBT works by using a chemical to detect a component of hemoglobin protein. 
Because this component, heme, is contained in some foods, dietary restrictions are 
necessary.136 FIT is an improvement to the FOBT because it uses antibodies to detect the 
specific hemoglobin protein in humans and requires no dietary restrictions.136 The DNA 
stool test use DNA mutations from the cells of the colonic mucosa (lining) as biomarkers 
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for CRC. For the most accurate results, individuals should collect samples from 
consecutive bowel movements.135  
Although they are less invasive and easy to administer on a large scale, stool tests 
have a higher false-positive rate, and they can only detect blood or DNA changes in the 
stool, which may be indicative of cancer.137 The U.S. Multi-Society Task Force 
(USMSTF) recommends a FIT every year as first-tier option, followed by a DNA stool 
test every three years as second-tier for average-risk populations.138 If a stool test returns 
positive, it will need to be followed up with a colonoscopy. A randomized control trial 
(RCT) comparing FIT, FOBT, and FS found participation rates to be higher for FIT, and 
FS detected cancer at a higher rate followed by FIT.139 Similarly, another RCT found a 
higher participation rate for FIT compared to colonoscopy, a comparable cancer 
detection, but a lower ability to detect adenomas.140 However, the adenoma detection 
potential increases for positive-FIT followed by colonoscopy procedures.141,142 
 
2.6.2 Imaging Tests 
These tests allow the physician to visualize the colon without having to enter the 
colon. In a double-contrast barium enema (DCBE), the patient is given an enema with 
barium solution. Then, multiple x-ray images of the entire colon and rectum. A virtual 
colonoscopy, or computed tomographic (CT) colonography, uses a CT scanner to take 
multiple pictures of the colon and rectum that can show polyps or other abnormalities. 
Imaging tests can be more expensive than stool tests, requires no sedation, but still 
require a colonoscopy if the tests have abnormal findings. The USMSTF recommends a 
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CT colonography every 5 years as a second-tier option for average risk populations.138 
The 2018 ACS guidelines does not recommend DCBE as a screening modality.134 
 
2.6.3 Optical Test 
Optical tests involve the insertion of a scope through the anus, which requires 
stricter bowel preparation. The scope pumps air so the doctor can have a better visual of 
the colon. A flexible sigmoidoscopy (FS) uses a sigmoidoscope, a tube with a lens, to 
exam the rectum and distal colon. The physician can remove abnormal lesions that were 
located for a biopsy. Sedation is not usually required for this test. A colonoscopy 
examines the entire colon and rectum and can remove abnormal growths. Because of this, 
it is considered the gold-standard of all screening tests.  
The USMSTF recommends a colonoscopy every 10 years as the first-tier option, 
followed by a FS every 5 years.138 These recommendations are made from consistent 
evidence of a beneficial effect. Epidemiologic studies show a 77% and 65% reduction in 
CRC incidence and mortality due to colonoscopy, respectively when compared to no 
screening.109,143,144 A meta-analysis on endoscopic screening revealed a 31% and 26% 
reduction in distal CRC incidence and mortality for FS in randomized control trials 
(RCT), respectively, which also included a one-time FS.145 Further, RCT evidence shows 
a slightly lowered risk of all-cause mortality after FS screening.146,147  
 
2.7 Surveillance after a CRC diagnosis 
 The number of cancer survivors continues to increase over time. In 2016, there 
were approximately 1.5 million CRC survivors (9% of all cancer survivors), and the 
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proportion is projected to be approximately the same by 2026 representing 1.8 million 
survivors.148 After a cancer diagnosis, patients undergo a myriad of events to progress to 
survivorship: surgery and treatment regimens, adjustment of lifestyle behaviors, and 
coping with the reality of cancer.149 One major adjustment is incorporating surveillance 
visits to prevent CRC recurrence. After curative resection of the colon or rectum, the 
USMSTF recommends the first surveillance colonoscopy one year after surgery, 
followed by a 3-year then 5-year colonoscopy.15 In addition to the this regimen, patients 
diagnosed with localized rectal cancer should also receive surveillance through FS every 
three to six months for 2-3 years following surgery. One study estimated that only 18-
61% of CRC survivors received a colonoscopy visit within 12-18 months of surgery.44 
The large variability in surveillance rates could be due to the cost. In addition, modifiable 
pre-diagnosis lifestyle factors like a healthy diet, PA, and not smoking have shown 
evidence in reducing the risk of CRC recurrence and prolonging survival.11,13,121,150 
 
2.8 Endoscopist  
 Receiving timely CRC screening is imperative in reducing CRC risk, but the 
physician that administers these recommended endoscopic procedures also play a role. 
Gastroenterologists (GE) are internal medicine physicians that complete additional, on-
going trainings to specialize in endoscopic procedures related to digestive health. 
Colorectal surgeons (CRS) are general surgeons that complete additional trainings for 
procedures of the colon and rectum. While GEs and CRSs perform a higher volume of 
colonoscopies, other physicians in general surgery and primary care (i.e. general internal 
medicine and family medicine) also perform colonoscopy.151  
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Differences in colonoscopy quality and later colorectal outcomes have been noted 
and vary by physician specialty.152–155 While colonoscopy reduces CRC mortality overall, 
a national case-control study found that colonoscopies performed by GEs had the lowest 
odds of CRC mortality compared to other specialties.156 A population-based Ontario 
study found that colonoscopies performed in hospitals by GEs reduced the risk of 
incident CRC compared to general surgeons.157 In the Medicare population, patients that 
received a colonoscopy from general surgeons or other physicians had 1.3 and 3.0 times 
the risk of interval cancer, respectively compared to GEs.158 In addition, CRSs were 
found to have better emergency surgery postoperative outcomes159 and lower mortality 
rates after rectal surgery160 compared to general surgeons. 
Quality measures of colonoscopy like the cecal intubation rate (CIR), adenoma 
detection rate (ADR), withdrawal time, and polypectomy rate are associated with 
decreased postcolonoscopy CRC (PCCRC),152,161–165 and also vary by endoscopist 
specialty. A Canadian study found that surgeons were half as likely to remove polyps that 
GEs.153 Likewise, a U.S. study of average risk adults undergoing colonoscopy screening 
found that GEs had a higher proximal sessile serrated adenomas detention rate compared 
to surgeons.166 In SC, the primary care physicians (PCPs) from the SC Medical 
Endoscopy Center receive training from GEs, CRSs, or a board-certified internist, and 
assistance from a gastrointestinal technician during the procedure. As a result, the quality 
metrics of CIR, polyp detection rate (PDR), ADR, withdrawal time, and minimal adverse 
events were comparable to the quality of GEs.167  
 Endoscopist volume is also related to the quality of the procedure, where quality 
metrics improve with the number of colonscopies,168,169 but differ greatly by endoscopist 
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specialty.170 Higher endoscopist and hospital volume were both found to be associated 
with a lower risk of mortality after colon cancer resection,171,172 and 5-year survival.155 In 
the Medicare population, surgeons that performed a very high volume of colon cancer 
resections had lower odds of postoperative complications.173 However, in a group of 
general surgeons, higher volume was not associated with the ADR.169 
 
2.9 Environmental Influences 
2.9.1 Socioeconomic status 
It has been said that socioeconomic status (SES) and zip code predicts our later health 
outcomes more than our genetic code. Epidemiologic studies have consistently shown 
that people with lower income have lower overall health, more hospitalizations, lower 
screening rates, and an overall lower life expectancy.174–177 Numerous factors like lower 
health literacy and limited access to healthy food outlets contribute to these disparities.178 
For example, a systematic review found low health literacy to be associated with less 
preventative visits, higher emergency room utilization, and a contributor to racial health 
disparities.179 The screening rate for CRC increases for every level of higher education as 
well as insurance status.86 When considering CRC incidence by poverty level, the 
decreasing trend applied to mainly moderate to high income areas.180  
 
2.9.2 Geographic location 
Public health literature consistently recognizes geographic location as determinant 
of health. The built environment influences and affects the decisions that people make 
about their health. In particular, geographic distance can be a barrier to accessing health-
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promoting opportunities and receiving health care.181 Individuals that live further from 
health facilities have lower screening rates182–184 and experience delayed or no care185,186. 
In addition, individuals that have less access or greater travel distance to care are often 
diagnosed with cancer at later stages187–189 and have a higher mortality rate190–192. Some 
studies have also found geographic distance to PA opportunities and healthy food outlets 
create negative outcomes and inequities in health. In particular, residents with more 
access to supermarkets and limited access to convenient stores and fast food restaurants 
tend to have healthier diets and lower prevalence of obesity.35 When multiple social 
determinants like race, SES, and geographic distance are interacting, CRC outcomes can 
be compounded.23,193 
Rural families tend to be at the disadvantage as it relates to geographic distance 
and health. Compared to rural residents, urban residents have more flexibility in choosing 
a health facility, more access to specialists, and shorter travel distances.194 For example, 
having more GEs reduced the delay in diagnosis in rural areas, but had no effect in urban 
areas.195 There are larger clusters of health services and specialty doctors in urban areas 
compared to rural.196 National studies reveal that as the level of rurality increase, the 
density of physicians decrease, with the most drastic declines in the proportion of 
available specialists.197,198 Particularly in SC, many of the endoscopists performing 
colonoscopy primarily practice in urban areas, which include 87% of GEs and 100% of 
CRSs.151 Thus, rural residents travel farther for overall care and CRC-related 
services.184,199,200 As a result of these differences in access to care, rural residents have 
lower screening rates.22,197,201  
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2.9.3 Obesogenic Environment 
 An obesogenic environment is defined as the sum of influences that the 
surroundings, opportunities, or conditions of life have on promoting obesity in 
individuals or populations.202 Chaput et al. noted that many of our modern comforts like 
readily available, high calorie food are counter to our natural biology.203 Obesity is a 
natural response to obesogenic environments.204 For example, a national study found the 
number of fitness centers and natural amenities to be negatively associated with obesity, 
while a higher number of fast food restaurants positively associated.205 Lower income 
areas suffer the most harm from obesogenic environments. In particular, lower income 
neighborhoods were found to have a higher density of fast food outlets compared to 
higher income neighborhoods.206 
There have been mixed findings about the relationship between the obesogenic 
environment and cancer. Canchola et al. found that traffic density was inversely 
associated with CRC risk in African American and Latino residents, but positively 
associated with White Americans.40 Conroy et al. found that mixed-land development 
was positively associated with breast cancer risk in Latino women, but negatively 
associated with White women.207 However, these studies did not find a significant 
association between the food and recreational environment with cancer, even with a large 
sample size. Therefore, it is possible that the obesogenic environment does not have a 




3.1 Data Sources 
3.1.1 SC Ambulatory Surgery Discharge Database 
The SC Ambulatory Surgery Discharge Database is an all-payer, population-
based ambulatory outpatient database for endoscopic procedure claims in South Carolina 
between 2000 and 2014. The procedures (colonoscopy or sigmoidoscopy) were identified 
by the ICD-9 and/or HCPCS procedure code (see Appendix A). The de-identified 
database was constructed by the Revenue & Fiscal Affairs Office in Columbia, SC in 
2017. Each claim (row) contains information about the patient, facility of procedure, and 
the physician(s) performing the procedure. The patient-level data include: a unique 
identifier, the month and year of the admission, diagnostic code(s), procedure code(s), 
payor, age group, race, sex, state, county and Zip code. The facility-level data include: 
name, address, county, and type. The physician-level data include: SC license number(s), 
physician National Provider Identification (NPI) number, and medical specialty. The 
2009 and 2013 SC Medical Board licensing directory and the 2017 NPI registry were 
used to supplement physician specialty information. 
 
3.1.2 Colorectal Cancer Prevention Network (CCPN) 
In 2008, the Center for Colon Cancer Research at the University of South 
Carolina established the CCPN, a statewide screening program that promotes education 
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and awareness of CRC. The CCPN is a collaborative effort of patient navigators, board-
certified gastroenterologists, licensed pathologists, and cancer treatment specialists. 
Eligibility for the program include: uninsured adults aged 50 – 64 (45 for African 
Americans) that lived at or below 150% of the federal poverty line and receive care from 
safety-net practices (like FQHCs and FMCs). Exclusion criteria include: having a 
colonoscopy within the last 10 years, symptoms of CRC, personal history of cancer, and 
other gastrointestinal-specific criteria. Colonoscopies were performed by board certified 
gastroenterologists, and diagnoses were confirmed by contracted pathologists. Data 
collection in this screening cohort includes over 1,000 variables about patient 
demographics, personal/family history, health behaviors, and clinical outcomes. The 
clinical outcomes include the colonoscopy results, quality metrics, and may include a 
pathology report about the findings of any cancer or lesions. More information about the 
CCPN can be found elsewhere.97 
 
3.1.3 South Carolina Central Cancer Registry (SCCCR) 
The SCCCR contains records for individuals diagnosed with cancer and living in 
SC from 2000 to 2014. For these aims, only a colorectal (colon or rectum) cancer 
diagnosis is relevant. This database contains demographic and clinical for data for each 
patient. The demographic information includes: sex, race, age, county, rurality, 2000 and 
2010 patient ZCTA, census tract poverty indicator, and unique identifier. The clinical 
information include month and year of diagnosis, cancer sequence number, primary site, 
behavior, histology, stage, grade, laterality, cause of death, death status, survival time. 
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3.2 Paper 1 
3.2.1 Study Population 
The SC Ambulatory Surgery Discharge Database will be used to identify unique 
patients that visited a center for a screening colonoscopy between 2010 – 2014. To isolate 
screening procedures, patients will be excluded if younger than 50 and older than 75 
years, had a previous CRC cancer diagnosis, a documented personal history of CRC, 
more than one colonoscopy within a 3-year period, or received an emergency 
colonoscopy. Personal history will be assessed based on procedure codes from the 
discharge database, and we will determine a previous cancer diagnosis by cross-
referencing patient identifiers in the SCCCR.  
 
3.2.2 Analysis 
We will create facility catchment areas (CAs) for each colonoscopy facility in SC 
based on the location (i.e., ZIP code centroid) of patients seeking screening 
colonoscopies from each respective facility. For each facility, we will create a dataset 
with patient demographic data, which includes sex, race, age group, insurance, and ZIP 
code. To estimate the proportion of patients (from each ZIP code) that chose to visit a 
given facility (n = 98), we will utilize hierarchical Bayesian logistic regression as laid out 
by Wang and Wheeler.208 The patient ZIP code will capture the residual effect after 
adjusting for demographic variables. The overall logistic model is: 
log  1 − 
 =  +  +  + ℎ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30 
where pij is the probability of person j from ZIP code i receiving a screening 
colonoscopy, and vi is the ZIP code-specific random effect. The random effect is 
expected to capture the remaining heterogeneity of each ZIP code, like the rurality, local 
policies and norms, and socioeconomic features. The reference group is female sex, white 
for race, the 50 – 59 group for age, and commercial/HMO for insurance. 
To fit the hierarchical Bayesian logistic model, we will use R2jags in R version 
3.5.2. The exceedance probability for assigning a ZIP code to a CA will be q = 0.95. The 
exceedance probability is estimated by calculating the number of ZIP code odds ratios 
(ORs) from the posterior samples that exceed one. We will map the CAs to illustrate the 
regions that do not fall in any catchment area (Figure 1). We will also create tables with 
descriptive statistics to compare the demographics of patients inside and outside the CAs 
(Table 2) and the effect of the variables on the CAs (Table 3) of select facilities. 
 
3.3 Paper 2 
3.3.1 Study Population 
This aim will utilize the CCPN data and the cohort that was screened between 
January 1, 2014 and August 31, 2018.  
 
3.3.2 Obesogenic Environment Score 
The obesogenic environment score is the exposure of interest and will be 
constructed using county and census tract data such as the median household income, 
food environment (retail, food deserts), neighborhood safety, and park availability. This 
score is currently in development by Principal Investigators Kaczynski and Eberth as part 
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of a cooperative agreement with the Health Resources and Services Administration 
(HRSA). The obesogenic environment score will be calculated at the county and census 
tract level using data from 2012 – 2014. The CCPN database will be merged to the 
obesogenic environmental score by the patient’s county of residence at time of 
enrollment in the CCPN Program. 
 
3.3.3 Outcomes 
The outcomes of interest are 1) presence of any histologically-confirmed polyp or 
adenoma and 2) presence of any histologically-confirmed high-risk polyp or adenoma. 
High risk polyps are defined as any polyp 1 cm or greater, including hyperplastic, any 
traditional serrated or sessile serrated adenoma/ polyp, any polyp w/villous components, 
and/or high-grade dysplasia.97 Low risk is considered to be all other polyps. Covariates of 
interest are age, sex, race, education, family history of CRC, obesity status (body mass 
index or waist-to-hip ratio), smoking history, alcohol consumption, comorbidities, 
urban/rural status, and area-level income. 
3.3.4 Analysis 
For this aim, we will estimate the effect of the obesogenic environment on the 
presence of polyps (overall and high-risk) through mediation analysis, where the 
mediator is obesity. We will use the mediation approach built from the counterfactual 
theory that incorporates exposure induced confounders (See Figure 3.1).209 In addition, 
we will perform a sensitivity analysis to estimate the unmeasured effect of diet since this 
is an important confounders were either unmeasured or unreliable. 
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We will construct a table of demographics of the CCPN cohort of all participants, 
those with polyps, and those with high-risk polyps (Table 1). An additional table with the 
mediated effects, the controlled, direct, direct, and the total effect (Table 2). This table 




Figure 3.1. Directed acyclic graph illustrating the relationship between the obesogenic 
environment and polyps through obesity.  
 
3.4 Paper 3 
3.4.1 Study Population 
The SC Ambulatory Surgery Discharge Database and the SCCCR will be merged 
to only include patients between the ages of 18 and 75 diagnosed with colorectal cancer 
between January 2001 and June 2013. Persons diagnosed in distant stage cancer, <65 
years with Medicare, with an inflammatory condition, and death before the surveillance 
window will be excluded. 
 
3.4.2 Outcome 
Colonoscopy records between 2001 and 2014 for those diagnosed with cancer 
will be linked to the patient records to create the main outcome variable: adherence to the 
Obesogenic 
Environment 






1-year surveillance colonoscopy. It will be a binary variable (yes or no). The 1-year 
window is measured as 9 – 18 months after date of CRC diagnosis. 
 
3.4.3 Analysis 
We will use multivariate log binomial regression to model the prevalence ratio of 
adherence to surveillance colonoscopy within one year. An interaction term between age 
and race will also be tested to directly address this aim. Covariates include sex, primary 
insurance, stage at diagnosis (local or regional), tumor site (colon or rectum) and 
residential location (urban vs. rural). Descriptive statistics will be calculated and 
compared by adherence status (Table 1). In bivariate analyses, we will use the Chi-square 
test for categorical covariates and t-tests for continuous covariates. A model results table, 
stratified by age group, will present the effect of the variables on the surveillance (Table 
2). Finally, we will calculate the age-adjusted prevalence of surveillance adherence over 










CATCHMENT AREA ANALYSIS FOR COLONOSCOPY CENTERS IN SOUTH 
CAROLINA1 
 
                                                           
1 Josey MJ, McLain A, Merchant AT, Eberth JM to be submitted to Health & Place 
35 
4.1 Abstract 
 Colorectal cancer (CRC) is the third most common cancer in adults but is mostly 
preventable through a healthy lifestyle and screening procedures like colonoscopy. While 
colonoscopy can be a life-saving procedure, obstacles like lack of awareness and distance 
to care, particularly for rural residents, continues to be a barrier. The purpose of this study 
was to explore the geographic distribution of colonoscopy services by creating catchment 
areas (CAs) around each colonoscopy facility in South Carolina (SC). 
 We used the SC Outpatient Ambulatory Surgery Database to identify adults who 
received a screening colonoscopy between 2010-2014. Adults were included if they were 
between the ages of 50-74 and living in SC and excluded if they had a personal or 
suspected history of CRC or CRC-related diseases. We performed catchment area (CA) 
analysis using 2-stage Bayesian hierarchical logistic regression, with a ZIP code random 
effect. We repeated this model for all colonoscopy facilities in SC.  
 Of the 98 colonoscopy facilities, 96 had at least one ZIP code within its CA and 
covered 88% of ZIP codes in SC. Many ZIP codes, particularly those in metropolitan 
areas, were included in 2-3 CAs. Only 2% of patients resided in a ZIP code that fell 
outside of a CA, which were mostly along the state border. 
 The colonoscopy facilities reached a large portion of SC. While this study was on 
the actual utilization of patients that chose to be screened, the distance and other non-
spatial barriers may still be present in the unscreened population.  
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4.2 Introduction 
 Colorectal cancer (CRC) is the third most common cancer in both men and 
women, and was estimated to be the 2nd leading cause of cancer death in South Carolina 
for 2018.210 However, CRC is mostly preventable through regular screenings and a 
healthy lifestyle, which could advert 58% and 50% of incident CRC cases in men and 
women, respectively.75 The U.S. Multi-Society Task Force (USMSTF) on CRC 
recommends colonoscopy as the primary tier procedure for CRC prevention because it 
can remove lesions from the colon, thus reducing or eliminating the potential for 
cancer.138 Research has shown that colonoscopy prevents an estimated 77% of CRC-
related deaths.109,143,144 
 Although colonoscopy can be a life-saving procedure, only 68% of age-eligible 
adults have received any CRC screening, with state-level rates as low as 50 - 60%, with 
adults aged 50 – 64 having the lowest rates.7 The USMSTF recommends that adults 
participate in screening from age 50 through 75.138 Barriers to screening, particularly for 
colonoscopy, include lack of awareness, cost, distance to care, and negative views about 
the procedure.8–10 While there have been improvements in public awareness and cost, 
distance continues to be a barrier, particularly for rural residents. People that live in rural 
areas travel a longer distance to colorectal screening and care, and have almost twice the 
travel time compared to urban residents.184,199 Amongst other factors, this obstacle 
manifests in higher incidence and mortality for rural residents.33,211  
 With largely preventable diseases like CRC, national committees set goals to 
increase screening utilization and reduce mortality rates. For example, HealthyPeople 
2020 published a goal for 70.5% of recommended eligible adults to be up-to-date with 
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CRC screening guidelines by 2020.212 More recently, the National Colorectal Cancer 
Roundtable set a goal for 80% of eligible adults to be up-to-date with screening by 2018 
and encouraged local agencies and health facilities to partner with the mission by taking a 
pledge to action.213 While these initiatives spark enthusiasm, they also draw attention to 
the issue of CRC screening capacity and handling an influx of new customers. In a 
simulation study, Joseph et al. found that in the first year, a colonoscopy-only screening 
program would require 16.2 million colonoscopies across the United States, with the 
maximum capacity (current and unrealized) being enough to handle the demand.214 While 
capacity may be adequate nationally, some counties and states have found mixed results 
in their ability to handle the growing demand.215,216 A study in Arizona found that urban 
and rural counties could increase their capacity by 36% and 53%, respectively, but only 
the urban counties needed more manpower to realize the maximum. In South Carolina 
(SC), the number of centers performing colonoscopy and the annual physicians volume 
of colonoscopies has noticeably increased in urban areas, but remained constant or 
declined over time in rural areas.151 Therefore, it is necessary for researchers and health 
care providers to know the geographic distribution of services as well as target areas for 
potential growth, where services are most underutilized and where resources can be 
shared or expanded. One way to make inferences on the capacity of health care services 
is to investigate the spatial distribution of available resources and the potential consumer 
demand. In the healthcare field, a catchment area (CA) is a geographic region that 
contains a population of people that are more likely to utilize services at a specific health 
facility. A simple CA may include the population of people that live within a 30-minute 
or 30-mile buffer of the facility. However, this method assumes that people that do not 
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live in close proximity will not use the services. CA analyses continue to grow in 
complexity by taking into account commuting and public transportation,217,218 urban 
versus rural driving normalcy,219,220 and competing businesses221. 
 We implemented a Bayesian Hierarchical method proposed by Wang and 
Wheeler that does not limit a CA to a specific distance or time boundary.208 This is 
particularly important because these factors may not be as important when seeking 
elected, specialty services like colonoscopy, particularly in regions outside of major cities 
where driving is the most feasible mode of transportation. Therefore, individuals that are 
willing to travel farther have a chance to be included in the CA. In addition, many CA 
methods estimate the potential accessibility, however this method allows for 
retrospective, patient-level data to estimate the realized accessibility. Another aspect of 
this CA analysis is that it can quantify and illustrate where individuals choose to get a 
colonoscopy, and how their demographic characteristics affect the formation of each CA. 
 Currently, the literature is limited for CA analysis of healthcare facilities, 
particularly colonoscopy centers. Much of the current literature in the United States 
revolves around primary care facilities as opposed to specialty services. The purpose of 
this project is to illustrate and describe the catchment areas (i.e. service areas) of facilities 
in SC providing screening colonoscopies from 2010 – 2014, and the travel patterns of 
their patients. Using data from the population-based SC Outpatient Ambulatory Surgery 
Database, we examined travel patterns of age-eligible adults seeking a colonoscopy in 
SC. Specifically, our study aimed to identify areas within the state that underutilize 
colonoscopy screening and describe the characteristics of patients within (or outside) 
existing CRC screening facility CAs. 
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4.3 Methods 
4.3.1 Data source 
 We used the all-payer, population-based SC Outpatient Ambulatory Surgery 
Database (ASD) for the years 2010 – 2014. This individual-level database houses 
demographic, insurance, zip code, and county data for colonoscopy patients, the SC 
license information and specialty code for physicians, and the name and address of the 
facility where the procedure was performed. The type of endoscopic procedure was 
classified using ICD-9, CPT, and HCPCS codes (see Appendix A). Only colonoscopy 
procedures were retained for this study. 
 
4.3.2 Study population 
 The target population was adults living in SC that were eligible for a screening 
colonoscopy. The patients in this study were between the ages of 50 and 74, which is the 
recommended age range for colonoscopy screening. To isolate the screening-eligible 
population, patients were excluded if they were diagnosed with cancer prior to the 
colonoscopy or had more than one colonoscopy within a 3-year window because these 
patients are more likely to be on a more intense, surveillance regime. Patients were also 
excluded if they received a colonoscopy in the emergency room, which indicates a 
diagnostic or non-elected procedure. 
 
4.3.3 Colonoscopy facility 
 Any SC facility performing at least one colonoscopy procedure for the screening-
eligible population between 2010 and 2014 was eligible for inclusion in this study.  
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4.3.4 Statistical Analysis 
 We utilized the method presented by Wang and Wheeler, specifically a 2-stage 
Bayesian hierarchical logistic regression.208 Our model estimates the probability, pij that a 
patient received a colonoscopy at a particular facility (yes or no). The model included a 
ZIP code random effect so we could estimate the residual variation in the odds of being 
screened at a facility after adjusting for demographic variables. For a ZIP code to be 
considered for inclusion in a CA, at least one patient from that ZIP code had to visit a 
colonoscopy facility. Therefore, if no one received a colonoscopy, all patients from that 
ZIP code was dropped from the analysis. The logistic regression model was: 
log  1 − 
 =  + + + ℎ +  60 + # 70 + %&'() *+,'+ + -ℎ *+,'+ + / 
where / is the random effect of ZIP code j for patient i. The priors for the β coefficients 
were chosen to be non-informative from the Normal distribution with mean zero and 
precision of 0.00001 (which is equivalent to standard deviation of 1 × 105). The prior on 
the random effect was Normal with mean zero and precision τ, where the prior on τ was 
also chosen to be non-informative from the Gamma distribution with parameters a = 0 
and b = 0.0005. We used two chains with 15,000 iterations each, a burn-in period of 
10,000 samples per chain, and a thinning rate of 2, resulting in a total of 5,000 posterior 
samples. The starting values for the first chain was zero for each α and β coefficient, and 
1 for τ. The starting values for the second chain was -1 for each α and β coefficient, and 
10 for τ. We repeated this process for each colonoscopy facility in SC. 
 To determine if a ZIP code was included in a CA, we used a threshold exceedance 
probability, qj. The exceedance probability is the number of times the odds ratio (OR) for 
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ZIP code j from the Monte Carlo Markov Chain (MCMC) posterior samples (after burn-
in) exceeded one. We chose qj ≥ 0.95, which means: at least 95% of the ORs from the 
MCMC samples were greater than one, which indicates that the association between ZIP 
code j and the facility is larger than average after adjusting for the covariates (these are 
similar to hypothesis tests that the random effects are greater than zero). Our choice of qj 
was more stringent than the conventional threshold chosen by Wang and Wheeler to try 
to capture ZIP codes that are truly included in a CA.208 We also performed a sensitivity 
analysis using a range of thresholds (0.85, 0.90, 0.95). 
The demographic variables included in the model were binary indicators for age 
group, sex, race, and insurance type. The reference level for each variable was 50 – 59 
age group, female, white, and commercial/HMO insurance. To reduce the collinearity 
between age and insurance, a public insurance category was created that included 
Medicare and Medicaid. We also compared the patients and results by rurality status. 
Rurality was categorized using the 2010 Rural-Urban Commuting Area (RUCA) Codes 
by the United States Department of Agriculture. RUCA codes categorize areas based 
upon their population density and commuting patterns.222 Patients were classified as 
either urban (codes 1.0, 1.1, 2.0, 2.1, 3.0, 4.1, 5.1, 7.1, 8.1, 10.1) or rural (4.0, 5.0, 6.0, 
7.0, 7.2, 8.0, 8.2, 9.0, 10.0, 10.2, 10.3). The univariate associations with the covariates 
and being included in a CA were compared using the Chi-Square test and the Wilcoxon 
Sum-Rank (because of skewness) test for continuous covariates. The Bayesian 
hierarchical logistic models were fit and the maps created using the R2jags package and 
ggplot2 package, respectively in R version 3.5.2. The complete address for each facility 
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(street, city, zip) was geocoded in ArcGIS Pro with a match rate of at least 98.6%, and 
the ZIP code shapefile was publicly available and provided by ESRI.223 
 
4.4 Results 
 There were 394,816 adults included in our study. Most of the colonoscopy 
patients were aged 60 – 69 (68%), female (56%), White (65%), used commercial/HMO 
insurance (53%), and resided in an urban ZIP code (93%); see Table 4.1. Only 9120 (2%) 
of patients resided in a ZIP code that was not included in a CA. The distance of the 
chosen colonoscopy facility was approximately two times the distance of the closest 
facility (5.71 vs. 11.86 miles), with rural patients traveling a greater distance, particularly 
for rural patients not within a CA. The age and sex demographic distribution of patients 
outside of a CA was similar to those within a CA. However, there was a larger proportion 
of White patients not included in CA (77% vs. 65%) and distribution of rural patients not 
included in a CA was significantly smaller (0.4% vs. 7%). 
 Between 2010 and 2014, there were 98 facilities that performed an average of 813 
(SD = 802) screening colonoscopies per year. The CAs included 476 different ZIP codes, 
covering 88% of ZIP codes in SC. The average number of ZIP codes within a CA was 16 
and ranged from zero to 63. Having zero ZIP codes in a CA means that a facility has no 
CA or had a very low chance of patients within those ZIP codes being screened there. On 
average, the longest distance patients within a CA traveled to the utilized facility was 8.7 
miles. The mean CA size increased slightly between the current cutoff value qj = 0.95 and 
0.85 to 18 ZIP codes, and the maximum distance traveled stayed consistent at 8.9 miles in 
the sensitivity analysis. Facilities located in urban counties collectively reached 87% of 
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ZIP codes compared to 75% for rural facilities. Of the 62 ZIP codes not included in a CA, 
15% were rural and clustered in the Midlands and Lowcountry counties bordering 
Georgia, which was similar to the overall distribution of rural ZIP codes in SC (13%).  
Figure 4.1 shows the distribution of catchment areas of facilities performing 
screening colonoscopies in SC, where darker colors indicate more overlap of the CAs. 
Many of the colonoscopy facilities were clustered in urban areas with the darker shading, 
particularly the Charleston, Greenville, and Columbia metropolitan areas. Approximately 
53% of the ZIP codes fell within 2-3 CAs, and ZIP codes with the most overlap (i.e. 12 
CAs) were surrounding or within the most populated areas of SC like Richland and 
Charleston counties.  
Table 4.2 shows a summary of the odds ratios of the variables included in the 
model for a sample facility in SC with a particularly large CA. Black patients and patients 
classified as Other race were significantly less likely to come to this facility (Black: OR = 
0.42, 95% Confidence Interval (CI): 0.40, 0.44; Other race: OR = 0.04, 95% CI: 0.03, 
0.04) compared to White patients. Those with public insurance were 29% less likely to 
come to this facility (OR = 0.71, 95% CI: 0.68, 0.75) and those with other insurance had 
25% lower odds of coming to this facility (OR = 0.75, 95% CI: 0.70, 0.79) compared to 
those with commercial/HMO insurance. This facility provided one of the highest annual 
volumes, and provided colonoscopy services to patients from across SC.  
 
4.5 Discussion 
 This study quantified and illustrated the CAs of centers providing screening 
colonoscopies in South Carolina using hierarchical Bayesian logistic regression. The CAs 
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of the colonoscopy facilities covered most ZIP codes in SC, overall and for urban and 
rural facilities separately. ZIP codes located in or near larger cities within the state had 
the most overlap and fell within multiple CAs. The CA sizes varied with most facilities 
having a large reach and span of customers across their county.  
 Like many specialty services, colonoscopy providers were clustered in urban 
areas. Although the facilities may compete for consumers, the CAs of these facilities 
overlap the surrounding population without a clear distinction. Wan et. al used a three-
step catchment area method to address overestimation of clustered facilities and identify 
shortage areas.221 Using the actual utilization of colonoscopy patients, our study was able 
to handle clustered facilities and  identified shortage areas, which were mainly located 
along the edges of the state (i.e. edge-effect). This may not indicate underuse of 
colonoscopy screening because some of these patients may choose to go to an out-of-
state facility in neighboring counties, which may be closer in distance and possibly 
covered by their employer and associated insurance plan. This is supported by our data; a 
larger proportion of patients in our study with commercial insurance were located outside 
of a CA than within compared to those with public insurance. In addition to the ZIP 
codes along the edges, ZIP codes that were comprised mainly of businesses (e.g. hospital 
and universities) were not estimated to be a part of any CAs, even if it was near a 
colonoscopy facility. 
Previous literature has shown that rural areas have more barriers to receiving care 
than urban residents.196,224 While rural patients in our study must travel farther for a 
colonoscopy, most patients from rural ZIP codes that chose to be screened were within at 
least one CA. McGrail and Humphreys used multiple distance buffers to account for rural 
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travelers.219 Without presetting distance thresholds, our study identified multiple CAs that 
rural ZIP codes fell within, with a wide range of travel distances. While the patients in SC 
seeking a colonoscopy had the ability to bypass their closest facility, the CAs for the 
facilities generally represented the ZIP codes in closest proximity. 
 The implications of this study lay the groundwork for understanding the screening 
capacity and accessibility of physicians performing colonoscopy in SC. A physician 
being physically available does not imply access. For the same population, a study 
estimated the density of colonoscopy providers by adjusting for annual volume and 
down-weighting physicians that performed few procedures per year.225 There were two 
facilities that did not have a CA, although they were identified as a colonoscopy facility. 
Thus, a simple count of physicians or facilities would overestimate the supply of 
physicians and facilities performing colonoscopy. In addition, a deeper investigation of 
the association of patient demographics on visiting a facility would further elucidate non-
spatial barriers. Although most ZIP codes were included in at least one CA, inclusion 
does not indicate barriers or burden of travel. The patients in this study are those that 
chose to be screened and do not account for the 31% of eligible residents in SC that were 
not up-to-date with any CRC screening.86 Future studies should consider the age-eligible 
population and their demographics to account for the unrealized potential. 
There are a few limitations to consider. The purpose of this data was billing of 
administrative claims, and the accuracy was dependent on those coding the data. 
However, this dataset was extremely large, and thus more robust to non-systematic errors 
in original data. We were also unable to include out-of-state patients in our analysis 
because we did not have complete information about colonoscopy utilization of 
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neighboring states, although they were present in the original data. Thus, measuring 
capacity for screening colonoscopy should consider cross-state health seeking activity. 
By linking databases across state lines, future studies can quantify the additional demand 
of out-of-state patients. Also, the CA formation was dependent on a subjective cutoff 
value. We chose to use a more conservative value than the conventional value,208 yet the 
results were similar and have a higher sensitivity, which was desired. Despite these 
limitations, using the population-based, all-payer ASD, this is the first study to quantify 
CAs for colonoscopy facilities for an entire state. Future studies should consider how 
CAs change as the health insurance landscape continues to evolve, specifically for 
screening or preventative procedures. 
 
4.6 Conclusion 
The reach of current facilities performing screening colonoscopies span the state 
of SC, leaving only a small proportion of residents outside of a CA. Urban facilities 
provided colonoscopy services for most SC patients. Yet, the presence of rural facilities 
remains important to serving current demands of rural residents, as well as the growing 
future capacity. 
 
Table 4.1. Characteristics of patients seeking a screening colonoscopy in South Carolina, 
2010 – 2014 
 
Characteristic All patients In CA Outside CA p-value 
n (%) 394816 (100) 385696 (98) 9120 (2)  
Age     
50 – 59  99825 (25) 97288 (25) 2537 (28) <0.001 
60 – 69 268696 (68) 262695 (68) 6001 (66)  
70 – 74 26295 (7) 25713 (7) 582 (6)  
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Sex     
Male 174839 (44) 170553 (44) 4286 (47) <0.001 
Race     
Black 73591 (19) 71825 (19) 1766 (19) <0.001 
White 256759 (65) 249724 (65) 7035 (77)  
Other 64466 (16) 64147 (17) 319 (3)  
Insurance     
Commercial/HMO 211756 (54) 206250 (53) 5506 (60) <0.001 
Public 152729 (39) 149500 (39) 3229 (35)  
Medicare 142300 (36) 139305 (36) 2995 (33)  
Medicaid 10429 (3) 10195 (3) 234 (3)  
Other 30331 (8) 29946 (8) 385 (4)  
Rurality     
Rural 26336 (7) 26296 (7) 40 (0) <0.001 
Distance (miles) Mean (SD)  
Nearest facility 5.71 (5.07) 5.69 (5.09) 6.61 (4.03) <0.001 
Urban 5.53 (4.92) 5.50 (4.94) 6.60 (4.03) <0.001 
Rural 8.26 (6.24) 8.26 (6.25) 8.86 (3.50) 0.129 
Chosen facility 11.86 (12.23) 11.92 (12.26) 9.16 (10.5) <0.001 
Urban 11.32 (11.72) 11.37 (11.75) 9.03 (10.2) <0.001 
Rural 19.39 (12.14) 19.36 (16.11) 43.71 (22.15) <0.001 
Footnotes: Distance was calculated as the straight-line distance from the ZIP code centroid to 
the colonoscopy facility. CA – Catchment Area 
 
 
Table 4.2. Odds ratios of patient demographics for a sample facility in South Carolina. 
Coefficient Odds Ratio 95% CI 
Male 0.91 (0.87, 0.95) 
Black 0.42 (0.40, 0.44) 
Other race 0.04 (0.03, 0.04) 
Age 60 – 69  1.05 (1.00, 1.10) 
Age 70 – 74  1.25  (1.14, 1.38) 
Public Insurance 0.71  (0.68, 0.75) 






Figure 4.1. Map of the 98 colonoscopy facilities and their catchment areas in South 




THE OBESOGENIC ENVIRONEMNT AND COLORECTAL POLYPS: A 
MEDIATION ANALYSIS APPROACH2
                                                           




 Adenomatous polyps, or abnormal growths in the colon or rectum lining, account 
for 96% of all CRCs. While individual behaviors like smoking and poor diet play a role 
in the development of colorectal polyps, the environment also contributes to cancer 
outcomes. The obesogenic environment is a neighborhood-level measure of obesity-
promoting attributes, and the relationship with CRC has mixed findings in the literature. 
The purpose of this study was to explore the pathways between the obesogenic 
environment and colorectal polyps. 
 The participants from this study were screened by colonoscopy through the 
Colorectal Cancer Prevention Network, a program for low-income, uninsured adults 
living in SC. Adults were included if they were 50-64 (or 45-64 for African Americans). 
We used mediation analysis to decompose the natural direct effect (NDE) and natural 
indirect effect (NIE) of the obesogenic environment on colorectal polyps through obesity. 
We considered both general and high-risk polyps as outcomes. We also ran a sensitivity 
analysis to adjust for unmeasured confounding. 
Of the 959 participants included in the study, 63% and 15% had at least one polyp 
or high-risk polyp, respectively. The NDE for having a high-risk polyp was 0.74 (0.44, 
0.99) for full-service restaurants. Obesity did not mediate the relationship between the 
obesogenic environment and colorectal polyps. The sensitivity analysis revealed that the 
food environment becomes more protective as unmeasured confounding increases. 
Most of the obesogenic environment did not reduce the risk of having colorectal 
polyps. While people may not be able to move to a better environment, creating a healthy 
lifestyle within any community can offset the neighborhood-level influences.
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5.2 Introduction 
 Colorectal cancer (CRC) is the third most common cancer and the second leading 
cause of cancer death in the United States (U.S.).210 In 2013, an estimated 800,000 
person-years of life lost was due to CRC.226 However, a healthy lifestyle and regular 
screening CRC can reduce occurrence of new cases and CRC-related deaths.1,6,7 
Approximately 90% of new CRC cases and deaths occur in adults aged 50 and older, 
respectively.86 Thus, the Multi-Society Task Force on CRC recommends screening for 
the average-risk population aged 50 – 75 years. Nationally, the CRC screening 
prevalence has increased for this group, from 52% in 2008 to 67% in 2014.227,228 
However, an estimated 63% of CRC deaths in 2010 were attributable to non-screening.132  
 Research shows a 77% and 65% reduction in CRC incidence and mortality, 
respectively due to receipt of at least one colonoscopy.143,144 Colonoscopy is the primary 
(first tier), recommended modality for cancer prevention due to its ability to remove 
potentially cancerous legions or polyps.134,138 Polyps are precursors to CRC and vary in 
size and location, where each contributes to the severity and development of CRC. 
Hyperplastic polyps are very common, but rarely develop into cancer,49 while 
adenomatous polyps account for 96% of all CRCs.7 Some lifestyle behaviors are 
associated with the development of polyps. For example, smoking was shown to increase 
the risk of serrated polyps, a highly malignant adenoma that accounts for 30% of CRCs.52 
In addition, poor diet, particularly those lacking fiber, and a lack of physical activity are 
hypothesized to increase the risk of CRC.66,116,117 Higher fiber diets and physical activity 
decrease the transit time of fecal bulk in the intestines, which reduces the exposure time 
of potential carcinogens on the colon lining.115,119 
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 While individual behaviors play a role in the development of CRC, the 
environment has also been shown to contribute to various cancer outcomes. Pesticides, 
radiation, fibers and dust, metals, and second-hand smoke have been found to be 
associated with an increased risk of multiple cancers, particularly organs in the 
respiratory system.229 Beyond influences of the physical environment, the “built 
environment” has more recently been investigated for its role in the development of 
cancer. People are nested within their communities, and while they are mobile, the ability 
to participate in health-promoting opportunities is often dependent on their immediate 
environment. For example living in a more walkable neighborhood was associated with 
higher physical activity levels.230 Better access to healthy food (e.g. from grocery stores 
or supermarkets) and limited access to convenience stores has been associated with 
healthier diets and healthier weight.35 Disparities arise because healthy food tends to be 
more expensive and lower income and rural residents live further from healthy food and 
closer to fast food.231 
 The obesogenic environment is a measure of neighborhood-level obesity-
promoting attributes, such as high density of fast food restaurants and fewer grocery 
stores and physical activity locations. Obesity is strongly correlated with CRC,2,232 with 
obese adults having a 20% higher risk of developing CRC than non-obese adults.232 
Obesity was also estimated to be attributable to 5.2% of CRC cases.75 Figure 1 shows our 
hypothesized, literature-supported relationship between the obesogenic environment, 
obesity, having at least one polyp identified during a screening colonoscopy.  
 There is a gap in the literature about the relationship between the obesogenic 
environment, individual level obesity, and CRC. A national study found traffic, vehicle 
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transit, and more restaurants to be associated with an increased risk of CRC in some 
ethnic subgroups.40 Further, the association between the obesogenic environment and 
precursors to CRC (i.e. polyps) has yet to be quantified. This study proposes to consider 
the bigger picture of the relationship between the obesogenic environment and polyp risk. 
Research consistently supports the path from the obesogenic environment to obesity,207 as 
well as the path from obesity to the presence of colorectal polyps.120,233 However, the 
path through obesity has yet to be quantified (see indirect pathway in Figure 3.1). While 
people that live in an obesogenic environment may develop CRC through obesity, this 
study seeks to determine if there is a direct effect of the environment on CRC 
independent of individual-level obesity. Using a standardized population that controls for 
many SES factors like income and insurance access, we will address the following aims: 
1. Examine the pathways between the obesogenic environment and the presence of 
CRC polyps. 
2. To explore whether the association of the obesogenic environment on the 
presence CRC polyp(s) differs by polyp type (any and high-risk). 
Hypotheses:  
1. The pathway between the obesogenic environment and having a polyp is mostly 
mediated through obesity. 
2. The direct pathway (not through individual-level obesity) has a stronger effect on 






5.3.1 Study Population 
 The participants from this study were screened through the Colorectal Cancer 
Prevention Network (CCPN), a program established by the Center for Colon Cancer 
Research at the University of South Carolina as a strategic method to reduce CRC 
morbidity and mortality disparities in SC. The CCPN is a navigation program that 
provides free colonoscopy screenings to low-income, uninsured adults by partnering with 
Free Medical Clinics and Federally Qualified Health Clinics throughout the state. The 
program utilizes the services of board-certified gastroenterologists, pathologists, and 
cancer treatment specialists. Additional information about the CCPN is available 
elsewhere.97 
 To be eligible for inclusion in the CCPN, potential participants had to be aged 50 
– 64 or 45 – 64 for African Americans, live at or below 150% of the federal poverty line, 
and uninsured. This analysis included CCPN participants who had a colonoscopy 
between January 2014 and August 2018. Individuals were excluded if they had a 
colonoscopy within the past 10 years, a personal history CRC, recently experienced 
CRC-related symptoms, a known history of inflammatory bowel disease, or a personal 
history of cancer other than skin cancer. CCPN gastroenterologists can also exclude 
individuals from screening based on other personalized factors such as morbid obesity. 
The program guidelines are in alignment with the U.S. Multi-Society Task Force 





 Valeri and Vansteelandt (2009) introduced a causal mediation analysis method 
using the counterfactual approach to decompose and estimate the controlled direct, 
natural direct, and indirect effects of an exposure on an outcome.234 In this study, the 
controlled direct and natural direct effects are equivalent because we do not believe that 
there is an interaction between the obesogenic environment and obesity. The controlled 
direct effect (CDE) is the average difference of having a polyp had all the participants 
lived in a highly obesogenic environment versus if all participants lived in a lower 
obesogenic environment across all obesity levels. Similarly, the natural direct effect 
(NDE) is the average difference of having a polyp had all the participants lived in a 
highly obesogenic environment versus if all participants lived in a lower obesogenic 
environment, and all participants were not obese. The natural indirect effect (NIE) is the 
average difference of having a polyp had all the participants lived in a highly obesogenic 
environment then became obese versus living in a highly obesogenic environment and 
not becoming obese. The same interpretations hold for high-risk polyps. 
 The assumptions for this causal mediation analysis are: no unmeasured 
confounding between the exposure and outcome, exposure and mediator, mediator and 
outcome, and none of the mediator-outcome confounders are induced (or caused) by the 
exposure. However, because diet is unmeasured, sensitivity analyses are necessary to 
estimate the possible effect on the results (Figure 3.1). The remaining variables in the 
minimally-sufficient set to control for confounding are income/SES, and the variables 
included in C. Because our population is restricted to low-income, uninsured adults in 
SC, this is a feasible model to estimate. 
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5.3.3 Exposure 
 The main exposure for this study is the obesogenic environment. The obesogenic 
environment index (OEI) was created by a team of researchers at the University of South 
Carolina in a project funded by the Federal Office of Rural Health Policy on childhood 
obesity. The process of constructing the index began with compiling area-level variables 
from a comprehensive literature review, then verifying them in an expert review. Ten 
final variables that were potentially associated with childhood obesity were included in 
the index, nine at the county level and one at the state level. The publicly available 
variables were the availability of: grocery stores and superstores, farmers markets, fast 
food restaurants, full service restaurants, convenience stores, exercise opportunities, 
school proximity, walkability, violent crime, and births at baby-friendly facilities (state-
level). Grocery stores/superstores, farmers markets, births at baby-friendly hospitals, 
exercise opportunities, school proximity, and walkability were hypothesized or 
previously shown to be inversely related to obesity and were reversed coded so that lower 
OEI meant a healthier environment. The variables were then ranked and allocated a 
percentile, where 0 = least obesogenic/healthy and 100 – most obesogenic/unhealthy. The 
final county-level OEI was the average percentile across all non-missing variables. Only 
6% of U.S. counties had missing data (1, 2, or 3 variables), with zero missing data for SC 
counties. We assumed that the patients lived in the same or a county with similar 






 The mediator was whether the participant was obese. Obesity status was 
determined by the standard definition of having a body mass index (BMI) greater than 30 
kg/m2. Measurement of height and weight were self-reported and compared to measures 
from recent office visits within 7 – 30 days of the colonoscopy. 
 
5.3.5 Outcome 
 The primary outcomes were 1) the presence of any histologically-confirmed 
colorectal polyp or adenoma (yes/no) and 2) the presence of any histologically confirmed 
high-risk polyp or adenoma. High risk polyps are defined as any polyp one cm or greater, 
including hyperplastic, any traditional serrated or sessile serrated adenoma/ polyp, any 
polyp w/villous components, and/or high-grade dysplasia.97 If participants did not have a 
subpathology report, they were removed from the high-risk polyp analysis (n = 237). 
 
5.3.6 Confounders 
 The variables considered for entry in the model were age at program inclusion, 
sex, race/ethnicity, highest attained education, family history of CRC, smoking history, 
alcohol consumption, non-steroidal anti-inflammatory drugs (NSAIDs) usage, physical 
activity, income level, and urban/rural designation. Age was categorized as 45-49, 50-54, 
55-59, and 60-64. Race/ethnicity was classified as Non-Hispanic Black, Non-Hispanic 
White, or other. Education was categorized as: less than high school (HS), GED or HS 
diploma, some college or Associate’s degree, or Bachelor’s degree or higher. Family 
history of CRC was determined if the participant reported having a mother, father, or 
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sibling ever diagnosed with CRC. NSAID utilization was indicated by NSAID or aspirin 
usage and categorized as daily, 4 – 6 days, 1 – 3 days, or zero days per week. Physical 
activity (PA) was measured as the number of days during the last week spent doing no, 
moderate, or vigorous physical activity. We categorized PA to be in close alignment with 
the standards for PA; whether a participant was moderately or vigorously active for zero 
days, 1-3 days, 4-6 days, and 7 days per week.  
 Smoking status was categorized using the CDC definition for never, former, and 
current smoker.235 Alcohol consumption was also determined by the CDC.236 Heavy 
consumption was defined as having greater than 14 and 7 drinks per week for men and 
women, respectively. Moderate consumption was having no more than two drinks and 
one drink per day (which we expanded to ≤14 and ≤7 per week) for men and women, 
respectively. And no consumption was zero drinks per week. ZIP code level median 
household income was obtained from the 2007-2011 American Community Survey, an 
ongoing survey performed by the U.S. Census Bureau that provides area-level 
sociodemographic information and categorized into tertiles.237 Urban/rural status was 
determined using the ZIP code approximated 2010 Rural-Urban Commuting Area 
(RUCA) Codes by the United States Department of Agriculture. RUCA codes categorize 
areas based upon their population density and commuting patterns.222 A participant was 
considered an urban resident if their ZIP code RUCA was metropolitan (RUCA = 1.0, 
1.1, 2.0, 2.1, 3.0, 4.1, 5.1, 7.1, 8.1, 10.1) and rural otherwise. Participants were excluded 




5.3.7 Statistical Analysis 
 We used the chi-square test for categorical variables in the univariate analysis. 
The mediation analysis utilized the product method described by Valeri and 
VanderWeele to estimate the decomposition of effects (direct and indirect) of the 
exposure on the outcome.238 The confidence intervals were estimated using 1000 
bootstrap samples. We used logistic regression to estimate the effect of the exposure on 
the mediator (obese vs. not obese) and loglinear regression to estimate the effect of the 
exposure and mediator on the outcome (polyp vs. no polyp). The parameter estimates 
from the two models were used to estimate the natural direct effect (NDE) and the natural 
indirect effect (NIE), which were interpreted as relative risks (RR). A sensitivity analysis 
for unmeasured confounding of a mediator-outcome confounder was conducted using a 
method proposed by Vanderweele and Chiba.239 The sensitivity analysis explores how the 
estimates would change over values of the expected relationship between the exposure, 
mediator, and all measured and unmeasured confounders on the outcome. We categorized 
the composite OEI and individual variables by classifying each as ‘high’ if greater than or 
equal to the 75th percentile and low otherwise. All variables in the OEI were in the 
analysis except availability of baby-friendly hospitals because it was a state-level variable 
and does not vary among participants in SC. Data management was carried out in R 







 The final sample included 959 adults that had a colonoscopy within the study 
period. Table 1 shows that most the study population was aged 50-54 (44%), non-
Hispanic Black (53%), obtained a high school diploma (42%), lived in an urban ZIP code 
(84%), had no family history of CRC (94%), and lived in a low-level obesogenic 
environment (73%). Many of the participants were also current (39%) or never smokers 
(40%), consumed moderate levels or no alcohol (47% each), were obese (51%), and 
either never took NSAIDs (32%) or took at least one NSAID daily (31%). The overall 
polyp detection was 63% and was higher in males (68% vs. 60%; p < 0.01), urban 
residents (65% vs. 54%; p = 0.02), current smokers (p < 0.001), and heavy drinkers (p = 
0.044). The high-risk polyp detection was 15% and did not vary by any demographic or 
lifestyle variables. 
 The mediation analysis revealed that features of the obesogenic environment were 
not associated with having any colorectal polyp. For high-risk polyps, the NDE was 0.74 
(95% CI: 0.44, 0.99) for full-service restaurants and non-significant for the remaining 
index and composite variables. Obesity did not mediate the association between the 
obesogenic environment and having a polyp or high-risk polyp. 
 The sensitivity analysis revealed that as the (realistic) differences in the outcome 
of having a polyp increased between the exposed and unexposed populations, the direct 
effect became stronger and more protective across the food environment, specifically 
grocery store and convenience store availability. The difference in the proportion of 
having a polyp across the exposure levels amongst obesity groups had to be at least 10% 
for the residual confounding to reduce the risk of polyps. Farmers markets and restaurant 
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access required stronger differences. The direct effect remained null across the physical 
activity environment and the overall composite score. For the high-risk polyps, the 
difference in the outcome by exposure and mediator required for the residual 
confounding to affect the risk of polyp was complex for many of the obesogenic 
variables. The food environment had similar findings as general polyps, however, fast 
food restaurant access only required a 1% difference. Access to PA locations and the 
composite OEI reduced the risk of high-risk polyps when differences were at least a 5%. 
As the difference in the outcome increased across the exposure populations (1%), the 
indirect effect of the exposure on the outcome through the obesity increased for all polyp 
types, increasing the risk of having a polyp. 
 
5.5 Discussion 
 Full-service restaurants had an unexpected direct and preventative effect on 
having a high-risk polyp. Obesity did not mediate the relationship between the individual 
variables or composite OEI on the risk of having a polyp. However, the sensitivity 
analysis showed how accounting for unmeasured confounding increased the strengths of 
the associations. Therefore, our hypotheses were somewhat confirmed in this study. 
Rather, elements of the obesogenic environment seem to have an independent effect on 
risk of polyps in this low-income, uninsured population. 
 Grocery/superstore availability has been hypothesized to be associated with 
positive health outcomes, although there have been mixed findings in the literature.35,240 
Cummins et al. found that after the establishment of a new grocery store, dietary habits of 
residents remained unchanged.241 Likewise, a longitudinal study found that grocery store 
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availability was unrelated to changes in fruit and vegetable consumption.242 Restaurants 
tend to be clustered in urban areas,231 so it is possible that these associations are 
indicative of the type of neighborhood and its associated assets that might contribute to 
more positive health outcomes (e.g., density of primary care physicians). Our study 
included area-level income and rurality; future studies could explore how the obesogenic 
environment affects the risk of polyps when considering the individual distance to food 
and the PA environments. 
 There have been various findings about the relationship between physical activity 
and CRC.124,244 Epidemiologic studies suggest that physical activity could prevent CRC 
by reducing or maintaining a healthy body weight, or improving circulation and 
metabolism.75,114,119 Boehmer et al. found that the being located farther from physical 
activity locations and feeling unsafe due to crime to be associated with obesity.245 
Another study found that non-socially isolated adults that lived in areas with more access 
to physical activity locations were less likely to be physically inactive.246 Through the 
sensitivity analysis, we found that having a higher availability of physical activity 
locations could potentially reduce the risk of high-risk polyps. Future studies on the 
obesogenic environment and cancer should also consider the social networks of 
individuals because the social environment can be more influential than the geography of 
the built environment.247 
 In this population, the polyp detection rate (PDR) for overall and high-risk for 
obese participants was slightly lower compared to the normal weight participants. This 
may be unique to the low-income, uninsured population, as overweight and obese adults 
overall tend to have more polyps than normal weight adults.248–250 This dynamic directly 
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affected the overall results of the study. Previous research have reported mixed findings 
about the availability of food outlets and body weight, noting that residential access to 
various types of food outlets does not encompass the total utilized food resources (e.g. 
while at work or in transit).243 Similarly, Fuzhong et al. found that positive OEI features, 
like walkability, was associated with a decrease in body weight, while negative features 
like fast food restaurants, was associated with an increase in body weight, among those 
that utilized these outlets.242 In our sensitivity analysis, we found that when accounting 
for unmeasured confounding, particularly individual diet, obesity mediated the 
relationship of the exposure on the outcome by increasing the risk of having a polyp, as 
the difference in the outcome across the exposure levels increased. In addition, we found 
that aspects of the food environment were possibly protective of colorectal polyps.  
 There are a few limitations to consider. Our data did not include information on 
individual diet patterns. However, we were able to include a sensitivity analysis that 
accounted for unmeasured confounding to find that the food environment may have a 
stronger effect on the risk of having a polyp. We also used county-level data to measure 
the area-level obesogenic environment. While counties are macro-level in nature, we 
were able to find a significant effect on the outcome. Future studies could utilize smaller 
areas to measure the neighborhood obesogenic environment, or a GIS approach to 
capture individual proximity. Despite these limitations, the CCPN cohort is ideal for 
making causal inferences on colorectal outcomes because it was a controlled population 
where many barriers to accessing colonoscopy were removed. The CCPN cohort also 
represents a hard-to-reach population, and more likely to contribute to those with higher 
incidence and mortality in SC, thus these estimates are extremely meaningful.  
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5.6 Conclusion 
Although the obesogenic environment is thought to be obesity-promoting, obesity 
did not mediate the effect of the environment on the odds of having polyp in a controlled 
population. There were direct effects of the environment on colorectal polyp risk. While 
people may not be able to move to a better environment, creating a healthy lifestyle 
within any community can offset neighborhood-level influences. Obesity is not the sole 
measure for health status, so future studies should examine the additional ways that the 
obesogenic environment affects CRC outside of the commonly studied pathways. 
 
 
Table 5.1. Characteristics of participants and polyp detection in the CCPN Program, 
January 2014 – August 2018. 
 




 Any polyp 
High-risk 
polyps a 
No. of participants (%) 959  606 (63.2) 114 (15.8) 
Demographics      
Age   p = 0.2642 p = 0.3149 
45 – 49  46 (4.0)  31 (67.4) 3 (8.1) 
50 – 54 422 (44.0)  252 (59.7) 45 (14.2) 
55 – 59 300 (31.3)  198 (66.0) 40 (17.7) 
60 – 64 191 (19.9)  125 (65.5) 26 (18.3) 
Sex   p = 0.0058 p = 0.2404 
Male 378 (39.4)  259 (68.5) 54 (17.6) 
Female 581 (60.6)  347 (59.7) 60 (14.4) 
Race   p = 0.4499 p = 0.3899 
Non-Hispanic Black 507 (52.9)  311 (61.3) 53 (14.1) 
Non-Hispanic White 399 (41.6)  260 (65.2) 53 (17.3) 
Other 53 (5.5)  35 (66.0) 8 (20.0) 
Education   p = 0.1815 p = 0.1576 
Less than High School 250 (26.1)  167 (66.8) 38 (20) 
High School Diploma 405 (42.3)  254 (62.7) 39 (12.6) 
Some college/Associate’s degree 243 (25.4)  154 (63.4) 29 (16.0) 
Bachelor’s degree or higher 60 (6.3)  31 (51.7) 8 (20.5) 
ZIP code-level income ($)   p = 0.0467 p = 0.1832 
≤ 35,297 338 (35.3)  197 (58.3) 45 (18) 
≤ 43,133 305 (31.8)  206 (67.5) 39 (16) 
65 
≤ 77,901 316 (33.0)  203 (64.2) 30 (12) 
Rurality   p = 0.0205 p = 0.1340 
Urban 801 (83.5)  519 (64.8) 91 (14.9) 
Rural 158 (16.5)  87 (55.1) 23 (20.5) 
Family History of CRC   p = 0.1090 p = 0.3213 
No 903 (94.2)  565 (62.6) 104 (15.4) 
Yes 56 (5.8)  41 (73.2) 10 (20.8) 
Obesogenic Environment   p = 0.5219 p = 0.2033 
Low 703 (73.3)  440 (62.6) 88 (16.9) 
High 256 (26.7)  166 (64.8) 26 (13.0) 
Lifestyle     
Smoking status   p < 0.001 p = 0.2568 
Never 386 (40.3)  215 (55.7) 35 (13.1) 
Former 196 (20.4)  122 (62.2) 24 (16.0) 
Current 377 (39.3)  269 (71.4) 55 (18.1) 
Alcohol Consumption   p = 0.0436 p = 0.8478 
None/Low 454 (47.3)  277 (61.0) 51 (15.3) 
Moderate 450 (46.9)  286 (63.4) 55 (15.9) 
Heavy 55 (5.7)  43 (78.2) 8 (18.6) 
Obesity   p = 0.5334 p = 0.3345 
Underweight 11 (1.2)  9 (81.8) 0 
Normal weight 172 (17.9)  111 (64.5) 26 (19.6) 
Overweight 288 (30.0)  184 (63.9) 32 (14.5) 
Obese 488 (50.9)  302 (61.9) 56 (15.6) 
NSAID Use   p = 0.0978 p = 0.7740 
None 303 (31.6)  202 (66.7) 38 (16.0) 
Occasionally  184 (19.2)  117 (63.6) 21 (15.8) 
1 – 3 days/week 129 (13.5)  86 (66.7) 19 (19.8) 
4 – 6 days/week 48 (5.0)  33 (68.8) 6 (15.8) 
Daily 295 (30.8)  168 (57.0) 30 (13.8) 
Procedure Quality     
Bowel Preparation   p = 0.4914 p = 0.7936 
Excellent/Good 868 (92.1)  551 (63.5) 101 (15.3) 
Fair/Poor 74 (7.9)  44 (59.5) 8 (16.7) 






Table 5.2. Decomposition of effects of the obesogenic environment on having a polyp 
 
 Decomposition of Effects (RR) 
Obesogenic Environment Index NDE NIE Total Effect 
Any Polyp     
Food Environment     
Grocery Stores ↓ 0.92 (0.81, 1.00)  1.00 (0.99, 1.00) 0.92 (0.81, 1.00) 
Farmers Markets ↓ 0.97 (0.87, 1.08) 1.00 (0.99, 1.00) 0.97 (0.87, 1.08) 
Convenience Stores ↑ 0.94 (0.74, 1.02)  1.00 (0.99, 1.01) 0.94 (0.74, 1.02) 
Full-Service Restaurants ↑ 1.01 (0.93, 1.09) 1.00 (0.99, 1.01) 1.01 (0.93, 1.09) 
Fast Food Restaurants ↑ 1.00 (0.92, 1.07) 1.00 (0.99, 1.00) 1.00 (0.92, 1.07) 
Physical Activity Environment     
School Access ↓ 1.04 (0.97, 1.14) 1.00 (0.99, 1.01) 1.04 (0.97, 1.14) 
PA Access ↓ 0.99 (0.90, 1.08) 1.00 (0.98, 1.00) 0.98 (0.90, 1.08) 
Walkability  ↓ 1.05 (0.97, 1.15) 1.00 (0.99, 1.01) 1.05 (0.97, 1.15) 
Violent Crime ↑ 1.02 (0.93, 1.10) 1.00 (0.99, 1.01) 1.02 (0.93, 1.10) 
Composite Score ↑ 1.01 (0.93, 1.09) 1.00 (0.99, 1.00) 1.01 (0.93, 1.09) 
High-Risk Polyp     
Food Environment     
Grocery Stores ↓ 0.91 (0.60, 1.27) 1.00 (0.98, 1.02) 1.26 (0.77, 1.96) 
Farmers Markets ↓ 0.91 (0.54, 1.35) 1.00 (0.98, 1.02) 0.91 (0.54, 1.35) 
Convenience Stores ↑ 0.86 (0.53, 1.17) 1.00 (0.98, 1.03) 0.86 (0.53, 1.17) 
Full-Service Restaurants ↑ 0.74 (0.44, 0.99) 1.00 (0.96, 1.03) 0.74 (0.44, 0.99) 
Fast Food Restaurants ↑ 0.78 (0.49, 1.03) 1.00 (0.98, 1.02) 0.78 (0.49, 1.02) 
Physical Activity Environment     
School Access ↓ 1.04 (0.68, 1.51) 1.00 (0.96, 1.03) 1.04 (0.68, 1.51) 
PA Access ↓ 0.86 (0.53, 1.21) 1.00 (0.97, 1.02) 0.86 (0.53, 1.20) 
Walkability  ↓ 1.05 (0.70, 1.51) 1.00 (0.96, 1.03) 1.04 (0.70, 1.48) 
Violent Crime ↑ 0.99 (0.67, 1.39) 1.00 (0.99, 1.02) 0.99 (0.67, 1.39) 
Composite Score ↑ 0.84 (0.53, 1.14) 1.00 (0.99, 1.01) 0.84 (0.53, 1.14) 
Footnotes: * p < 0.05, ** p < 0.001 
The logistic and loglinear models used to calculate the natural direct effect (NDE), natural indirect effect 
(NIE), and the total effect (TE) adjusted for sex, smoking status, weekly alcohol consumption, NSAID use, 
ZIP code-level income and rurality. The controlled direct effect (CDE) = NDE since both the exposure and 
mediator are binary. The decomposed effects are interpreted as risk ratio (RR). The high-risk mediation 
analysis was based on the 722 participants that had a subpathology report. The arrows represent the 





INCREASED INSURANCE ACCESS AND SURVEILLANCE OF COLORECTAL 
CANCER3
                                                           




Surveillance colonoscopy is recommended one year after a colorectal cancer 
(CRC) diagnosis and treatment to prevent cancer recurrence, but uptake is suboptimal 
and understudied among minority populations. We examined whether racial disparities in 
adherence to surveillance are less pronounced over time in older (age 65+) versus 
younger CRC survivors (age <65) due to improved access to health insurance. 
We linked colonoscopy records from the population-based, all-payer SC 
Outpatient Ambulatory Surgery Database from 2001-2014 to the SCCCR to identify 
those diagnosed with a primary CRC from 2001-2013. We calculated the age-adjusted 
prevalence of one-year surveillance and used multivariable loglinear regression to model 
the prevalence ratio of adherence to colonoscopy within one year (9-18 months) after 
CRC diagnosis. Covariates included race, sex, primary insurance, stage at diagnosis and 
urban/rural status. The final model was stratified by year of diagnosis (2001-2007 and 
2008-2013) to determine if disparities persist over time.  
 Among the 9016 survivors included in the study, 5041 (56%) received a 
colonoscopy within 1-year of diagnosis. The difference in adherence between White and 
Black survivors fell from 9.2% to 3.7% for men and 8.9% to -1.0% for women from 2002 
to 2013. Among younger male survivors, the prevalence of adherence was 14% lower in 
Black versus White survivors over time. However, the disparity was no longer present in 
the older survivors in the later years. 
 The disparity in receiving a 1-year surveillance colonoscopy diminished over time 
between Black and White survivors, but younger Black male survivors remained at 





 Colorectal cancer (CRC) is the third most common cancer in the United States 
(U.S.) and the third leading cause of cancer death in both men and women in 2018.1 The 
recent decline in CRC incidence and mortality has been attributed to increased screening 
and improved treatment.2 The 5-year survival rate has also increased over time, ranging 
from 14% for distant stages to 90% for localized stages.3 Although there are overall 
improvements in morbidity, mortality, and late staging of CRC, racial and socioeconomic 
disparities in CRC outcomes persist.4,5  
 The burden of a cancer diagnosis does not necessarily end with treatment. Cancer 
survivorship begins when a person is diagnosed and continues until death. In 2016, there 
were approximately 1.5 million CRC survivors in the U.S.,6 a 25% increase from 2012.7 
In addition to coping with a life-altering disease, life after a cancer diagnosis includes a 
plethora of changes including treatment, interacting with new doctors, adjusting to a 
wellness plan, and handling financial stresses.8 The Institute of Medicine and the 
National Research Council name prevention, surveillance, intervention, and coordination 
as essential components of survivorship care in the health care delivery system.9 For CRC 
survivors in the U.S., having health insurance is imperative to begin to navigate this 
system and help alleviate the added financial stress. For example, in the U.S., the average 
out-of-pocket cost of a colonoscopy is $3000,10 a cost that is typically absorbed under the 
Affordable Care Act when it is considered a preventive, screening procedure. However, 
for diagnostic or surveillance procedures including post-CRC colonoscopy, individuals 




ethnic minorities are less likely to receive cancer follow-up care,11 and face more 
financial hardship during survivorship12. 
 The U.S. Multi-Society Task Force on CRC recommends a surveillance 
colonoscopy one year after curative resection (treatment) of the colon or rectum, 
followed by a three-year and five-year colonoscopy.13 Observational studies and 
randomized controlled trials found surveillance colonoscopies to be associated with 
reduced CRC recurrence and improved overall survival.13 A systematic review in 2013 
found that 18 – 61% of survivors received a post-treatment colonoscopy within 12 – 18 
months.14 Adherence to surveillance colonoscopy among specific subgroups is not as 
well-studied as screening adherence,15,16 therefore disparities have also yet to be 
quantified. While there have been improvements in CRC screening uptake over time, 
these results cannot simply be extrapolated to CRC surveillance. While many states have 
established CRC screening programs and insurance coverage is more comprehensive for 
screening, few have done so focusing on surveillance following cancer diagnosis. 
 The purpose of this study was to determine adherence to guideline-concordant 
surveillance colonoscopy, overall and by racial subgroup, over time in South Carolina. 
We hypothesize that the disparity between older (65+ years) Black and White CRC 
survivors will be significantly reduced compared to younger CRC survivors (<65 years) 









6.3.1 Data Sources 
  The South Carolina Ambulatory Surgery Database (ASD) is a retrospective, 
longitudinal population-based data set of outpatient procedures performed in SC. Using 
ICD-9 and HCPCS codes (in Appendix A.1), we identified records indicating 
colonoscopy between 2001 and 2014. This database provides patient demographic and 
procedure information like age, race, sex, insurance, county, zip code, and colonoscopy 
date. The South Carolina Central Cancer Registry (SCCCR), one of the National Program 
of Cancer Registries, contains records on all individuals diagnosed with cancer in SC. In 
addition to demographic characteristics, the registry has clinical data like age at 
diagnosis, stage, location, grade, laterality, cause of death, and survival time.  
The ASD was merged with the SCCCR by a unique, de-identified patient 
identifier to determine if a cancer patient received a colonoscopy after CRC diagnosis. 
The ASD database was constructed and merged with the SCCCR by the South Carolina 
Revenue & Fiscal Affairs (RFA) Office in 2017. 
 
6.3.2 Study Population 
 The target population for this study was adults living in SC that were diagnosed 
with a primary CRC between January 2001 and June 2013. Survivors were included if 
they were adults between the ages of 18 and 75. This upper age limit coincides with the 
current CRC screening guidelines; there is no standard for surveillance colonoscopy in 
elderly patients; it is based on the individual life expectancy.17 Individuals were excluded 




surveillance recommendations were based on patients in stages I – III.13  Individuals were 
also excluded if they were younger than 65 years and their primary payer was Medicare 
because these patients tend to be less healthy prior to a diagnosis due to co-occurring 
disease such as end-stage renal disease (ESRD). We also excluded individuals that died 
before the end of the surveillance window. Finally, individuals were excluded if 
diagnosed with an inflammatory condition (e.g. Crohn’s disease, ulcerative colitis, 
irritable bowel syndrome) to reduce the likelihood of accounting for patients that had a 
total colectomy.  
 
6.3.3 Outcome 
 The outcome of interest was whether an individual received a colonoscopy 1 year 
after a CRC diagnosis (yes/no). The 1-year window was measured as 9 – 18 months after 
CRC diagnosis to allow for scheduling difficulties and post-diagnosis clearing 
procedures. 
 
6.3.4 Statistical Analysis 
 We used multivariable log binomial regression to model the prevalence ratio (PR) 
of adherence to the 1-year surveillance colonoscopy. An interaction term between age (at 
diagnosis) and race was included to assess if there are differences in the adherence 
prevalence. We divided the study window into two (semi-equal) time periods to 
determine if racial disparities were consistent over time: diagnosis year between 2001-
2007 or 2008-2013. Demographic covariates included were sex, primary insurance 




categorized into Black, White, or Other. The final model considered all race by sex 
subgroups, as heterogeneity exists within these groups,3,18 however model results for 
‘Other’ race will not be reported due to the small sample size. Rurality was defined using 
the 2003 Rural-Urban Continuum Code (RUCC) Codes by the United States Department 
of Agriculture. A survivor was considered an urban resident if their county RUCC was 
considered metropolitan or urban (RUCC = 1,2,3) and rural otherwise (RUCC=4-9). 
Clinical covariates were stage at diagnosis (local or regional), and primary cancer site 
(colon or rectum).  
 Because both the ASD and SCCCR are population-based databases, including a 
near census of colonoscopies provided and cancers diagnosed in SC, we calculated the 
age-adjusted prevalence of surveillance adherence for each year using the Surveillance, 
Epidemiology, and End Results Program (SEER) guide for calculating age-adjusted 
rates.19 The adherence prevalence was measured for the year following the diagnosis. We 
calculated the prevalence for the overall population and by race and sex subgroups from 
2002 – 2013. Differences in demographics variables were calculated using the Chi-square 
test, and the significance level was 0.05. 
 
6.4 Results 
 There were 8,869 patients included in the final sample (Figure 1). The age-
adjusted prevalence of adherence to the 1-year surveillance colonoscopy post-diagnosis 
was 55.7% for CRC survivors in SC across the entire study period and remained stable 
over time; 57.0% in 2002 to 54.0% in 2013 (ptrend = 0.17). White survivors had a 




study period (58.2% vs. 50.0%, p < 0.001). Over time, the racial difference in 
colonoscopy adherence by sex diminished. Figure 2 shows that adherence difference 
between White and Black men fell from 9.0% in 2002 to 3.0% in 2013 (ptrend = 0.10). For 
women, the difference between White and Black survivors fell from 9.4% in 2002 to -
0.7% in 2013 (ptrend = 0.002; see Appendix B.1).  
 Table 1 shows that survivors residing in urban areas had a higher adherence 
prevalence compared to rural survivors (57.6% vs. 51.4%, p < 0.001), and those with 
Other insurance or that self-paid for the procedure had a lower prevalence compared to 
commercial/HMO and Medicare (p < 0.001). Those diagnosed with colon cancer were 
more likely to adhere compared to rectal cancer survivors (p < 0.001), and a higher 
proportion of survivors that received the 1-year colonoscopy were alive at the end of the 
study (p < 0.001). 
 The interaction between race and age was significant in the log binomial model (p 
< 0.001). Table 2 shows that Black male survivors were approximately 13% less likely to 
adhere to the 1-year surveillance colonoscopy compared to White males for the younger 
age group across both time periods. Older Black males were less likely to adhere 
compared to White males in the early study period [PR = 0.73, 95% Confidence Interval 
(CI): (0.62, 0.87)] but were no different in the later years [PR = 1.01 (0.86, 1.18)]. 
Younger Black females were less likely to adhere to the surveillance colonoscopy in the 
early years compared to White men [PR = 0.82 (0.73, 0.92)], but were no different in the 
later years [PR = 0.98 (0.88, 1.10)]. There were no significant differences between older 




 Younger survivors that self-paid were less likely to adhere compared to those with 
commercial/HMO insurance for the early years [PR = 0.72 (0.61, 0.85)] and the later 
years [PR = 0.85 (0.74, 0.98)]. For the older age group, there were significantly fewer 




 This study quantified the prevalence of adherence to surveillance colonoscopy 
after CRC diagnosis over time and determined if increased access to health insurance 
reduced racial disparities in colonoscopy adherence. Over half (56.0%) of CRC survivors 
received their first surveillance colonoscopy within the recommended timeframe. This 
study showed that young White survivors had a higher prevalence of adherence and were 
more likely to receive a colonoscopy compared to young Black (male) survivors, 
regardless of the time period. However, this disparity was eliminated for the older age 
group (65+ years) in the later end of the study period, supporting our hypothesis of 
diminished racial disparities in the older population.
 In comparison to our estimated SC statewide adherence rate (56%), a study using 
electronic medical records of health systems across various states also found that 55% of 
CRC survivors received a colonoscopy within 18 months of curative surgery.20 Overall, it 
is difficult to compare studies because of different study settings and analytic designs. 
For example, a cancer institute in Alberta, Canada observed an adherence rate of 67% 
where their study participants were enrolled in a surveillance program.21 Older national 




Medicare-eligible and younger populations.22,23 Our study shows the reduction in these 
disparities over time and also reflects how surveillance uptake has increased over time, 
particularly for older Black survivors, but not yet for younger Black survivors. 
 Our results show the powerful role that insurance can play in the health care 
delivery system. Survivors younger than 65 years that self-paid were less likely to adhere 
compared to all other insurance types. While disparities diminish when opportunities are 
available, access to health insurance is not always enough to completely remove the 
financial burden that comes with being a cancer survivor. For example, Lee and Salloum 
found that Black and Hispanic survivors were two times more likely to experience cost-
related medical non-adherence compared to White cancer survivors.12 Under the 
Affordable Care Act, colonoscopies for high-risk individuals, particularly those with a 
personal history (i.e. survivors), will more than likely have to share the cost of the 
procedure.24   
 There are limitations of this study to consider. There was no available individual-
level socioeconomic (SES) variable in the cancer registry or ambulatory surgery 
discharge database. When using surrogate SES variables at the aggregate level, like the 
census tract poverty index, the values were similar across adherence groups and were not 
significant in a univariate model. However, primary insurance is highly correlated with 
household income,25 and was included in the models. It is possible that an accurate 
measure of individual SES is a true confounder and explains the remaining difference in 
prevalence by race. A Veteran’s Affairs study found that White veterans were 32% less 
likely than Black veterans to receive a surveillance colonoscopy within 7 – 18 months.26 




needed a surveillance colonoscopy. However, survivors included in the study were 
diagnosed in local and regional stages and no record of an inflammatory disease. Total 
colectomy is mainly an option for adults with inflammatory diseases or genetic 
conditions, which represents a very small proportion of CRC cases.27 We were unable to 
include CRC survivors in the model if they had no colonoscopy record in the ambulatory 
surgery discharge database, which houses their insurance information. This could include 
CRC survivors receiving their surveillance colonoscopies out-of-state or within the 
Veteran’s Affairs healthcare system. However, this only accounted for 7% of the total 




 This study highlights reductions in racial disparities in surveillance colonoscopy 
following CRC diagnosis. Closing the surveillance adherence gap is instrumental in 
reducing the overall burden of CRC. Access to health insurance coverage seems to play a 
role in these improvements. Future studies should monitor surveillance adherence 
following CRC as the landscape of insurance availability and cost continues to evolve in 















n (%) p-value 
 56.0 (54.9, 57.0)  4964 (56.0) 3905 (44.0)  
Demographic      
Sex      0.041 
Male 54.9 (53.0, 56.9)  2561 (51.6) 2101 (53.8)  
Female 57.1 (55.1, 59.1)  2403 (48.4) 1804 (46.2)  
Age     0.017 
18 – 64 57.1 (55.3, 58.9)  2913 (58.7) 2192 (56.1)  
65 – 75 54.5 (52.3, 56.7)  2051 (41.3) 1713 (43.9)  
Race     <0.001 
White 58.2 (56.6, 59.7)  3766 (75.9) 2710 (69.4)  
Black 50.1 (47.2, 53.0)  1143 (22.8) 1131 (29.0)  
Other 50.0 (37.8, 62.2)  64 (1.3) 64 (1.6)  
Primary Insurance     <0.001 
Commercial/HMO 58.5 (56.5, 60.4)  2495 (50.3) 1773 (45.4)  
Medicare 56.1 (53.8, 58.4)  1770 (35.7) 1385 (35.5)  
Medicaid 52.3 (45.8, 58.9)  223 (4.5) 203 (5.2)  
Self-Pay 45.4 (38.3, 52.4)  192 (3.9) 231 (5.9)  
Other 47.6 (41.8, 53.4)  284 (5.7) 313 (8.0)  
Rurality     <0.001 
Urban 57.6 (56.0, 59.2)  3762 (75.8) 2770 (70.9)  
Rural 51.4 (48.6, 54.3)  1202 (24.2) 1135 (29.1)  
Census Tract Poverty      <0.001 
<5% 60.9 (56.6, 65.2)  508 (10.1) 330 (8.3)  
5 – <10% 58.6 (55.7, 61.5)  1144 (22.7) 813 (20.4)  
10 – <20%  55.3 (53.1, 57.8)  2003 (39.6) 1615 (40.7)  
20 – 100% 53.4 (50.8, 56.1)  1379 (27.5) 1207 (30.6)  
Clinical       
Stage     <0.001 
Local 53.2 (51.3, 55.2)  2529 (50.9) 2221 (56.9)  
Regional 59.1 (57.2, 61.1)  2435 (49.1) 1684 (43.1)  
Primary Site     <0.001 
Large Intestine 58.6 (57.0, 60.1)  3930 (79.2) 2780 (71.2)  
Rectum 47.9 (44.8, 50.9)  1034 (20.8) 1125 (28.8)  
Alive at study end 58.4 (56.8, 60.0)  3734 (75.2) 2661 (68.1) <0.001 
Footnotes: The unadjusted prevalence of the 1-year surveillance colonoscopy (95% CI) and 
the proportion of those that did and did not adhere to across the study period. 
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Table 6.2. Adjusted prevalence ratios (95% CI) stratified by diagnosis year and age group 
for adherence to the one-year surveillance colonoscopy. 
  2001 – 2007 2008 – 2013  
< 65 Population 
Race by sex White male 1.00 1.00 
White female 1.04 (0.98, 1.12) 1.06 (0.98, 1.15) 
Black male 0.87 (0.78, 0.97) * 0.86 (0.76, 0.98) * 
Black female 0.82 (0.73, 0.92) *** 0.98 (0.88, 1.10) 
Rurality Urban 1.00 1.00 
Rural 0.87 (0.80, 0.94) *** 0.91 (0.84, 0.99) * 
Insurance Commercial/HMO 1.00 1.00 
Medicaid 0.86 (0.74, 1.00) 0.98 (0.87, 1.10) 
Self-Pay 0.71 (0.60, 0.85) *** 0.85 (0.74, 0.98) * 
Other 0.82 (0.72, 0.93) ** 0.87 (0.77, 0.98) * 
Stage Local 1.00 1.00 
Regional 1.15 (1.08, 1.22) *** 1.10 (1.03, 1.18) ** 
Primary Site Large Intestine 1.00 1.00 
Rectum 0.83 (0.77, 0.90) *** 0.78 (0.71, 0.85) *** 
 
Race by sex White male 1.00 1.00 
White female 0.97 (0.90, 1.05) 1.01 (0.91, 1.13) 
Black male 0.73 (0.62, 0.87) *** 1.01 (0.86, 1.18) 
Black female 0.91 (0.81, 1.04) 1.02 (0.88, 1.19) 
Rurality Urban 1.00 1.00 
Rural 0.89 (0.82, 0.97) ** 0.93 (0.83, 1.04) 
Insurance Commercial/HMO 1.00 1.00 
Medicare 1.10 (0.97, 1.26) 1.15 (1.00, 1.32) * 
Medicaid 0.41 (0.12, 1.42) 0.96 (0.61, 1.51) 
Self-Pay 0.91 (0.51, 1.62) 0.65 (0.28, 1.49) 
Other 0.63 (0.35, 1.13) 0.49 (0.24, 1.01) 
Stage Local 1.00 1.00 
Regional 1.08 (1.00, 1.16) * 1.03 (0.94, 1.13) 
Primary Site Large Intestine 1.00 1.00 
Rectum 0.88 (0.79, 0.97) * 0.83 (0.72, 0.95) ** 










Figure 6.2. Age-adjusted prevalence of one-year surveillance colonoscopy in South 







This dissertation provides a wide view of CRC, from screening access to 
surveillance uptake. This is the first study to examine the CAs colonoscopy facilities for 
an entire state, specifically using a method that modeled the realized demand. We also 
used a unique approach to learn how the obesogenic environment affects colorectal 
polyps, through different pathways. Finally, we provided the one-year surveillance 
colonoscopy prevalence over time for the population of CRC survivors in SC and 
identified racial disparities. 
 Chapter 4 illustrated how the colonoscopy centers in SC provided services for 
patients across the entire state. Overall, the CA method was able to examine the realized 
accessibility or utilization of patients receiving a screening colonoscopy in SC. The 
catchment areas of these facilities span 88% of the ZIP codes in SC, leaving only a small 
fraction outside of CAs, which were mainly along the state borders. Fifty-three percent of 
the ZIP codes fell into 2-3 different CAs, which were typically located near the most 
populated areas in SC. Diving further into each CA could elucidate accessibility to 
facilities beyond geography. While most of the ZIP codes were included in at least one 
CA, the patients in this study only represented individuals seeking a screening 
colonoscopy and do not account for diagnostic or surveillance colonoscopies. Future 




procedures in order to expand these results to estimating the true available screening 
capacity of colonoscopy providers.
 The obesogenic environment measures the obesity-promoting aspects of a 
neighborhood or community. While there have been mixed findings between the 
obesogenic environment and CRC, work needs to be done to understand the relationship 
with the precursor to CRC, or polyps. Polyps that continue to grow without being 
removed can progress to cancer. In Chapter 5, we found that full-service restaurants had a 
direct effect on having high-risk polyps. Our sensitivity analysis showed that when 
accounting for unmeasured confounding, the positive aspects of the food environment 
had the potential to reduce the risk of having a polyp. Research has shown that living in 
an unhealthy environment does not always imply that one would have an equivalent 
lifestyle. Even if one lives in an unhealthy environment, making good health decisions 
within those communities can offset the overall effect of the environment. Our sensitivity 
analysis also showed that obesity does mediate the effect of the obesogenic environment 
on having a polyp and increased the risk of colorectal polyps. Future studies should 
investigate what aspect of the obesogenic environment not through obesity has an effect 
on colorectal polyps (e.g. water and air quality). 
 In Chapter 6, we explored whether increased access to health reduced racial 
disparities in surveillance colonoscopy over time. Surveillance colonoscopies are 
beneficial to survivors to prevent recurrence of CRC and prolong survival. The 
prevalence of receiving a surveillance colonoscopy in SC decreased slightly over time 
from 57% to 54% overall, from 58% to 56% for White men, 49% to 53% for Black men, 




For adults younger than 65 years, there was a disparity in receiving a surveillance 
colonoscopy where Black survivors were 14% less likely to receive the colonoscopy 
compared to White survivors during both time periods. For Medicare-eligible adults at 
least 65 years in age, the disparity was eliminated in the later study period. Having more 
access to health insurance played a role in reducing the disparity in receiving timely care 
to prevent cancer recurrence. Future studies could investigate how the disparities change 
as the health care market continues to evolve, particularly for those that were formerly 
uninsured. 
 Colorectal cancer is primarily preventable through a healthy lifestyle, which 
includes regular screening colonoscopies and surveillance colonoscopies for recurrence 
prevention. For SC, most of the age-eligible adults for CRC screening have access to 
available resources. In addition to having available colonoscopy facilities, having access 
to healthy outlets is beneficial to adults in reducing the risk of colorectal polyps. Taking 
these steps have shown to prevent CRC. However, once CRC is discovered, early if 
screened regularly, survivors can prolong their survival by receiving regular surveillance 
colonoscopies. Future qualitative studies can explore what empowers individuals to 
engage in healthy decision-making (like health screenings) in order to help tailor 
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CODES TO IDENTIFY COLONOSCOPY 
Table A.1. CPT, HCPCS, and ICD-9 codes to identify colonoscopy in outpatient dataset 
 
Code Description 
G0105 Colorectal cancer screening; colonoscopy on individual at high risk 
G0121 Colorectal cancer screening; colonoscopy on individual not meeting the criteria 
for high risk 
44388 Colonoscopy through stoma 
44389 Colonoscopy through stoma with biopsy 
44390 Colonoscopy through stoma with foreign body removal 
44391 Colonoscopy through stoma with control of bleeding 
44392 Colonoscopy through stoma with hot biopsy 
44393 Colonoscopy through stoma with ablation of tumor(s), polyp(s) or other lesion(s) 
not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique 
44394 Colonoscopy through stoma with snare 
44397 Colonoscopy through stoma with transendoscopic stent placement 
45355 Transabdominal colonoscopy via colotomy 
45378 Colonoscopy 
45379 Colonoscopy with foreign body removal 
45380 Colonoscopy with biopsy 
45381 Colonoscopy with submucosal injection 
45382 Colonoscopy with control of bleeding 
45383 Colonoscopy with ablation of tumor(s), polyp(s) or other lesion(s) not amenable 
to removal by hot biopsy, forceps, bipolar cautery or snare technique 
45384 Colonoscopy with hot biopsy 
45385 Colonoscopy with snare 
45386 Colonoscopy with dilation 
45387 Colonoscopy with transendoscopic stent placement 
45391 Colonoscopy with endoscopic ultrasound 
45392 Colonoscopy with endoscopic ultrasound with FNA 
45.21 Transabdominal endoscopy of large intestine 
45.22 Endoscopy of large intestine through artificial stoma 
45.23 Colonoscopy 
45.25 Endoscopic biopsy of large intestine 
45.41 Excision of lesion or tissue of large intestine 
45.42 Endoscopic polypectomy of large intestine 
45.43 Endoscopic destruction of other lesion or tissue of large intestine 
48.24 Endoscopic biopsy of rectum 





PREVALENCE ESTIMATES OVER TIME 





 Men  Women 
 White Black  White Black 
2002 57.0  58.2 49.2   60.4 51 .0 
2003 58.9  59.2 44.9   67.6 51.2  
2004 53.8  55.0 51.7   56.3 45.7  
2005 57.5  60.1 47.9   61.1 49.9  
2006 55.2  57.5 43.7   61.7 49.6  
2007 55.7  60.0 44.1   61.9 41.6  
2008 53.8  58.9 46.5   52.8 48.1  
2009 55.5  55.2 59.8   54.1 55.8  
2010 53.8  55.3 45.2   58.5 50.4  
2011 58.2  58.5 47 .0  62.3 64.1  
2012 55.4  52.1 47.6   61.7 58.9  
2013 54.2  55.9 52.9  53.2 53.9 
 
 
